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dTDP deoxythymidine diphosphate
dTTP deoxythymidine triphosphate
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FucT fucosyltransferase
Gal galactose
GalE UDP-galactose 4-epimerase
GDP guanosine diphosphate
GlcNAc N-acetyl-D-glucosamine
GMD GDP-D-mannose 4,6-dehydratase
GMER GDP-4-keto-6-deoxy-D-mannose epimerase/reductase
GTS GDP-6-deoxy-D-talose synthetase
HPLC high-pressure liquid chromatography
LacNAc N-acetyllactosamine; Galβ1-4GlcNAc
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Lea Lewis A; Galβ1-3(Fucα1-4)GlcNAc
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Lec Lewis C; Galβ1-3GlcNAc
Lex Lewis X; Galβ1-4(Fucα1-3)GlcNAc
Ley Lewis Y; (Fucα1-2)Galβ1-4(Fucα1-3)GlcNAc
LJP localized juvenile periodontitis
LPS lipopolysaccharide
MALDI-TOF MS matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry
NADP+ nicotinamide adenine dinucleotide phosphate (oxidized form)
NADPH nicotinamide adenine dinucleotide phosphate (reduced form)
Neu5Ac N-acetylneuraminic acid
NMR nuclear magnetic resonance
O-PS O-polysaccharide
ORF open reading frame
RMD GDP-4-keto-6-deoxy-D-mannose reductase
RmlA glucose-1-phosphate thymidylyltransferase
RmlB dTDP-D-glucose 4,6-dehydratase
RmlC dTDP-4-keto-6-deoxy-D-glucose 3,5-epimerase
RmlD dTDP-4-keto-6-deoxy-L-mannose reductase
SDR short chain dehydrogenase/reductase
SDS-PAGE sodium dodecyl sulfate-polyacrylamide gel eletrophoresis
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9Multiple drug-resistance of pathogens creates a high demand for drugs, which act
with new strategies. Inhibition of host – pathogen interaction is a potential target for
interventions of novel antibacterial therapeutics. Cell surface polysaccharides situated
at the interface between the bacterium and its environment have important roles in
environment – bacteria interaction, especially in host – pathogen interactions. Hence,
manipulation of the biosynthesis of bacterial cell surface polysaccharides may influence
the interplay between host and pathogen.
The biosynthesis of cell surface glycoconjugates involves specific glycosyltransferases
utilizing nucleotide sugars as activated donors. Recently, an interest in the nucleotide
sugar metabolism of bacteria has been increased, because bacterial cell surface
polysaccharides contain unique monosaccharides. Hence, the biosynthetic pathways
of these monosaccharides could be considered as potential targets for antibacterial
agents. Drugs inhibiting the enzymes involved in the nucleotide sugar pathways specific
for bacteria might not interfere with human metabolic pathways and thus might not be
harmful for humans. However, detailed studies are needed to fully understand the
enzymology related to bacterial nucleotide sugar metabolism.
In this study, the nucleotide sugar synthesizing enzymes, that convert GDP-D-mannose
into GDP-L-fucose, GDP-D-rhamnose and GDP-6-deoxy-D-talose, were identified and
characterized at molecular level. GDP-D-mannose 4,6-dehydratase (GMD) and GDP-
4-keto-6-deoxy-D-mannose 3,5-epimerase/reductase (GMER) enzymes synthesizing
GDP-L-fucose were characterized from Helicobacter pylori, GDP-D-rhamnose
synthesizing GDP-4-keto-6-deoxy-D-mannose reductase (RMD) was characterized
from Pseudomonas aeruginosa, and GDP-6-deoxy-D-talose synthesizing GDP-6-
deoxy-D-talose synthetase (GTS) was characterized from Actinobacillus
actinomycetemcomitans serotype a. These microorganisms are Gram-negative
pathogens, in which deoxyhexoses L-fucose, D-rhamnose and 6-deoxy-D-talose are
constituents of LPS. In Gram-negative bacteria, LPS molecules are major integral
components of the outer membrane, which faces the environment surrounding the
bacteria.
In addition, a solid-phase extraction and an ion-pair reversed-phase high-pressure liquid
chromatography methods were developed for sample preparation and analysis of
synthesized nucleotide sugars, respectively.
SUMMARY
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Cell surface polysaccharides are situated at the interface between a bacterium and its
environment thus having  important roles in environment – bacteria interplay, especially
in host – pathogen interplay. In Gram-negative bacteria, lipopolysaccharides (LPS)
are major integral components of the outer membrane facing the environment
surrounding the bacteria. LPS has been shown to play a role in the variety of biological
effects associated with Gram-negative sepsis. Furthermore, LPS contribute to the
structural properties of the cell envelope and provide a selective permeability barrier.
LPS consist of three different components: lipid A, core oligosaccharide and O-antigen
(reviewed in Lerouge and Vanderleyden, 2002; Raetz and Whitfield, 2002).
O-antigen, which is the most exposed part of the LPS, consists of repeating units
made up of varying, usually from three to five, numbers of monosaccharides. The
structural diversity of O-antigens is remarkable; The O-antigen can be a linear or
branched homopolymer or, more frequently, a heteropolymer. The O-antigen can also
be modified nonstoichiometrically with glycosylation or by the addition of
noncarbohydrate substituents, e.g. by acetylation and methylation. The chemical
structure of O-antigen can be strain-specific, but it can also vary within a single strain.
The primary role of O-antigen appears to be protective. The exact role of O-antigen in
different bacteria is variable and can be potentially magnified in bacteria that can
produce more than one chemically distinct O-antigen (reviewed in Lerouge and
Vanderleyden, 2002; Raetz and Whitfield, 2002).
For decades tremendous efforts have been made to determine the exact chemical
structure of various O-antigen molecules. Recently, much effort has also been put
towards elucidating the enzymology involved in O-antigen biosynthesis. O-antigens
are synthesized from nucleotide sugars by specific glycosyltransferases that catalyze
the transfer of monosaccharides to the growing oligo- or polysaccharide structure
(Figure 1). In general, there is at least one specific glycosyltransferase for each
monosaccharide and specific linkage formed between a monosaccharide and an
acceptor molecule. To date, a large number of prokaryotic glycosyltransferases with
different donor, acceptor and linkage specificities have been cloned and characterized
(Unligil and Rini, 2000).
Nucleotide sugars are activated sugar metabolites which act as donors in glycosylation
reactions. Recently, interest in the nucleotide sugar metabolism of bacteria has
increased, because bacterial cell surface polysaccharides contain unique
monosaccharides that are not found in humans and because enzymes involved in the
conversions of nucleotide sugars are potential targets for manipulating substrate levels
available for polysaccharide glycosyltransferases. Manipulation of the biosynthesis
of bacterial cell surface polysaccharides may influence the host – pathogen interaction
or even the viability of a bacterium. Hence, the biosynthetic pathways of bacterial
nucleotide sugars could be considered as potential targets for interventions of
antibacterial therapeutics. These enzymes do not have human homologs thus drugs,
1. INTRODUCTION
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Figure 1. Panel A illustrates a model for linear O-antigen assembly via the ABC-transporter
dependent mechanism. The assembly requires NDP-sugar (nucleotide diphosphate sugar),
specific glycosyltransferase enzymes (T) and an initiating enzyme (INIT). The ABC-transporter
formed by the Wzm and Wzt proteins is required for transfer of the O-antigen polymer to the
periplasmic face of the inner membrane, where the LPS assembly is completed before
translocation to the outer membrane of a bacterium (reviewed in Lerouge and Vanderleyden,
2002; Raetz and Whitfield, 2002). NMP, nucleoside monophosphate; NDP, nucleoside
diphosphate. Panel B illustrates the schematic presentation of the architecture of branched,
heteropolymeric LPS. Noncarbohydrate substituents may be present in nonstoichiometric
amounts, e.g. fatty acids (zig-zag lines) and phosphoryl residues (circles) (reviewed in Lerouge
and Vanderleyden, 2002; Raetz and Whitfield, 2002).
which inhibit them might not interfere with metabolic pathways in humans. However,
more detailed studies are needed to fully understand the enzymology related to bacterial
nucleotide sugar metabolism.
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In this thesis, the cloning and functional characterization of enzymes involved in the
synthesis of nucleotide sugars, GDP-L-fucose, GDP-D-rhamnose and GDP-6-deoxy-
D-talose, are described. Enzymes were cloned from the Gram-negative pathogens
Helicobacter pylori, Pseudomonas aeruginosa and Actinobacillus
actinomycetemcomitans, which contain L-fucose, D-rhamnose and 6-deoxy-D-talose,
respectively, as constituents of their LPS O-antigen or distinct O-polysaccharide (also
known as capsular polysaccharide).
L-fucose, D-rhamnose and 6-deoxy-D-talose are 6-deoxyhexoses. In general,
deoxysugars are an important class of carbohydrates that are formed from common
monosaccharides by replacement of one or more hydroxyl groups with hydrogen, e.g.
in the formation of 6-deoxyhexoses the C6 carbon is deoxygenated. 6-deoxyhexoses
are formed from nucleoside diphosphate-activated hexoses via a 4-keto-6-deoxy
intermediate (Figure 2). In addition to LPS, deoxysugars can also be found in
extracellular polysaccharides (EPS) and antibiotics in bacteria (reviewed in Johnson
and Liu, 1998; Trefzer et al., 1999).
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2.1. Prevalence of fucose
Fucose is a deoxyhexose sugar found widely in the glycoconjugates of prokaryotes
and eukaryotes. Of the two isomers, L and D, the former is much more common and
the latter is rare and not found in mammals. D-fucose is found in a limited number of
both Gram-negative and Gram-positive bacteria, in which it is a constituent of the cell
wall and capsule structures. The activated nucleotide sugar form of D-fucose is dTDP-
D-fucose (Figure 2), which is synthesized from dTDP-D-glucose via dTDP-4-keto-6-
deoxy-D-glucose by dTDP-D-glucose 4,6-dehydratase (RmlB, EC 4.2.1.46) and dTDP-
4-keto-6-deoxy-D-glucose reductase (EC not yet classified) (Yoshida et al., 1999).
The activated nucleotide sugar form of L-fucose is GDP-L-fucose, of which the
biosynthetic pathway (Figure 3) is described in detail in section 2.3.
 L-fucose is an important component of the complex glycoconjugates of species ranging
from bacteria to mammals. In humans, L-fucose is an essential component of N-linked
and O-linked glycoproteins and glycolipids that mediate intercellular adhesion and
recognition processes and thereby play a role in immunity, inflammation and metastasis
of malignant cells (reviewed in Lowe, 2001; Tonetti et al., 1998). Specifically, L-
fucose is present in the human ABO blood group antigens and Lewis glycans. For
example, the sialyl Lewis X glycans, a crucial decoration of selectin ligands have
been demonstrated to have a role in leukocyte rolling and extravasation into tissues
(reviewed in Lowe, 1997).
L-fucose is also a constituent of the cell wall and capsule structures of Gram-negative
and Gram-positive bacteria. For instance, most E. coli strains as well as the other
species of the Enterobacteriaceae family are known to produce L-fucose containing
EPS colanic acid (reviewed in Whitfield and Roberts, 1999). In addition, L-fucose has
Table 1. Prevalence of L- and D-isomers of fucose, rhamnose and 6-deoxy-talose in
humans and in various strains of microorganisms used in this study
6-deoxy- 6-deoxy-
D-mannose D-fucose L-fucose D-rhamnose L-rhamnose D-talose L-talose
H. pylori + a - + a + b - - -
P. aeruginosa + c - - + c + c - -
A. actinomycetemcomitans + d + e - - + e + d + d
E. coli + f - + f - + - +
S. cerevisiae + g - - - - - -
Human +  f - + f - - - -
References: (dAmano et al., 1989; gHashimoto et al., 1997; bKocharova et al., 2000;
ePerry et al., 1996; reviewed in cRocchetta et al., 1999; fTonetti et al., 1998; aWang et
al., 2000)
2. L-FUCOSE PATHWAY
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Figure 2. Proposed biosynthetic pathways for nucleotide sugar precursors for L- and D-
isomers of fucose, rhamnose and 6-deoxy-talose. GLK, glucokinase (EC 2.7.1.2); PGI,
phosphoisomerase (EC 5.3.1.9); PMI, Phosphomannoisomerase (EC 5.3.1.8); PMM,
phosphomannomutase (EC 5.4.2.8); GDP, manno-1-phosphate guanylyltransferase (EC
2.7.7.22); GMD, GDP-D-mannose 4,6-dehydratase (EC 4.2.1.47); GMER, GDP-4-keto-6-
deoxy-D-mannose 3,5-epimerase/reductase (EC not yet classified); RMD, GDP-4-keto-6-deoxy-
D-mannose reductase (EC 1.1.1.187); GTS, GDP-6-deoxy-D-talose synthetase (EC 1.1.1.187);
PGM, phosphoglycomutase (EC 5.4.2.2); RmlA, glucose-1-phosphate thymidylyltransferase
(EC 2.7.7.24); RmlB, dTDP-D-glucose 4,6-dehydratase (EC 4.2.1.46); RmlC, dTDP-4-keto-
6-deoxy-D-glucose 3,5-epimerase (EC 5.1.3.13); RmlD, dTDP-4-keto-6-deoxy-L-mannose
reductase (EC 1.1.1.133); Tll, dTDP-4-keto-6-deoxy-L-mannose reductase (EC 1.1.1.133);  gene
product of fcd, dTDP-4-keto-6-deoxy-D-glucose reductase (EC not yet classified); GDP,
guanosine diphosphate; dTDP, deoxythymidine diphosphate. Because the nomeclature of these
enzymes is not uniform, the Enzyme Commission (EC) numbers are also represented. In the
text, enzymes are referred to by the names mentioned in this figure. However, it is worth
mentioning that according to the bacterial polysaccharide gene nomenclature (BPGN) the
recommended name for the enzyme responsible for GDP-4-keto-6-deoxy-D-mannose 3,5-
epimerase/reductase (GMER) activity is Fcl (Reeves et al., 1996). In this thesis, GMER is
used to refer to GDP-4-keto-6-deoxy-D-mannose 3,5-epimerase/reductase both in prokaryotes
and in eukaryotes.
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been shown to be a substantial cell wall component of several human pathogens, e.g.
H. pylori (reviewed in Appelmelk et al., 2000), E. coli O:157 (Barua et al., 2002;
Wang and Reeves, 1998), Campylobacter fetus (Moran et al., 1994), Yersinia
enterocolitica O:8 and several serotypes of Y. pseudotuberculosis (reviewed in Skurnik
and Zhang, 1996). L-fucose is also a structural component of the Nod-factors that are
important signals in the nodulation of the genera of plant microbes Azorhizobium and
Rhizobium (reviewed in Carlson et al., 1994; Trefzer et al., 1999).
2.2. L-fucose in H. pylori LPS
H. pylori, a microaerophilic bacterium, is an important human gastric pathogen,
infecting about half of the world’s population. H. pylori is a major cause of chronic
gastritis and plays a role in the other gastric diseases like duodenal ulcers, gastric
ulcers, gastric cancer and gastric lymphoma (reviewed in Marshall, 2002). The O-
antigen of LPS in most H. pylori strains contains fucosylated Lewis glycans,
predominantly the type II antigens Lewis X (Lex) and Lewis Y (Ley) (Figure 6).
Serologically, 80-90% of H. pylori strains express Lex and/or Ley epitopes (Simoons-
Smit et al., 1996; Wirth et al., 1996). In addition, i-antigen, blood group A antigen,
sialyl Lex, Lewis disaccharide, and the type I antigen like Lea, Leb, and H Type I
antigen (Figure 6) have been found in the O-antigen of H. pylori LPS (Table 2). Lewis
antigens expressed by H. pylori are structurally similar to human Lewis blood group
antigens. This restricted diversity in the O-antigen expression of H. pylori is unusual
and suggests a role for specific epitopes in pathogenesis. Additionally, H. pylori Lewis
antigens can undergo phase variation, which is the random, reversible high-frequency
switching of phenotype within a single strain (reviewed in Wang et al., 2000). A recent
study demonstrated that acidic environment can trigger phase variation from Lex to
Ley expression (Moran et al., 2002). The antigenic phase variation is most probably
beneficial to H. pylori in adaptation to different environments and environmental
changes, but its role in colonization and pathogenesis is unclear. However, phase
variation has been demonstrated to contribute to the virulence of bacteria like Neisseria
spp. (van Putten, 1993) and Haemophilus influenzae (Humphries and High, 2002;
Weiser and Pan, 1998).
Table2. The chemically characterized Lewis structures of H. pylori strains
H. pylori strain Lewis glycan Reference
26695 Lex, Ley, Le disaccharide, Linear Blood group (Monteiro et al., 2000)
J99 Lex, Ley (Monteiro et al., 2000)
P466 Lex, sialyl Lex, Ley (Monteiro et al., 2000)
NCTC11637 Lex, Ley, H Type I (Aspinall et al., 1996)
NCTC11639 Lex (Wang et al., 2000)
UA802 Ley (Wang et al., 1999)
UA948 Lea, Ley (Monteiro et al., 1998)
UA915 Leb, H Type I (Monteiro et al., 2000)
UA1111 Lea, Leb, H Type I (Wang et al., 2000)
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H. pylori – host interaction is under extensive study, and the whole genome sequences
of two H. pylori strains have been determined (Alm et al., 1999; Tomb et al., 1997).
During the studies several hypotheses have been made for the possible roles of Lewis
antigens in the course of colonization and/or persistent infection of H. pylori. The
molecular mimicry of human Lewis antigens has been proposed to protect H. pylori
from antigen-specific host defences and thus aid the persistence of its infection.
Furthermore, the H. pylori Lewis antigen have been suggested to induce autoantibodies
against the host gastric epithelia and cause autoimmune-mediated inflammation and
thereby contribute to the H. pylori infection. However, there are contradictory
observations about these hypotheses. Currently, the best evidence for the role of H.
pylori Lewis glycans is that they may play a role in the adhesion or colonization of the
bacterium to the host gastric mucosa (reviewed in Appelmelk et al., 2000; Gerhard et
al., 2002; Moran and Prendergast, 2001). Especially, H. pylori Lex has been suggested
to mediate adhesion to gastric epithelial cells and to be essential for colonization
(Appelmelk and Vandenbroucke-Grauls, 2000; Edwards et al., 2000; Martin et al.,
2000; Osaki et al., 1998).
2.3. GDP-L-fucose metabolism
GDP-L-fucose is synthesized in vivo via two different metabolic pathways. In the
salvage pathway, which is not found in bacteria, GDP-L-fucose is synthesized from L-
fucose derived from exogenous sources by the action of a L-fucose kinase (EC 2.7.1.52)
and a GDP-fucose pyrophosphorylase (EC 2.7.7.31) (reviewed in Bulter and Elling,
1999).
The de novo pathway of GDP-L-fucose (Figure 3), which is evolutionarily conserved,
is more prominent. It was first identified in bacteria in the 1960s (Ginsburg, 1960),
and then described in mammals (Overton and Serif, 1981), invertebrates (Bulet et al.,
1984) and plants (Liao and Barber, 1972). This pathway starts from GDP-D-mannose,
which is converted into GDP-L-fucose in three steps by two enzymes. The first reaction
step is a dehydration of GDP-D-mannose, which leads to the formation of an
intermediate product, GDP-4-keto-6-deoxy-D-mannose, and which is catalyzed by a
GDP-D-mannose 4,6-dehydratase (GMD, EC 4.2.1.47) (reviewed in Allard et al., 2002).
GMD catalyzes oxidation of the C4 group of the mannose ring to a keto form and the
subsequent reduction of the C6 group to a methyl group. During the concerted action
of oxidation and reduction an intramolecular hydride transfer occurs from the C4
position to the C6 position on the mannose ring by a tightly bound NADP cofactor,
which is essential for the activity of GMD (Oths et al., 1990).
In the second reaction step the intermediate product, GDP-4-keto-6-deoxy-D-mannose,
subsequently undergoes epimerisation at positions C3 and C5, which leads to a change
of D- to L-configuration and the formation of GDP-4-keto-6-deoxy-L-galactose. Finally,
a NADPH-dependent reduction of the keto group at the C4 position of GDP-4-keto-6-
deoxy-L-galactose leads to the formation of GDP-L-fucose. The last two steps of the
pathway are catalyzed by a bifunctional enzyme GDP-4-keto-6-deoxy-D-mannose 3,5-
epimerase/reductase (GMER, also known as Fcl/WcaG in E. coli and FX in man, EC
not yet classified) (reviewed in Allard et al., 2001). GMER can utilize NADH or
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NADPH as a cofactor, but NADPH has been demonstrated to be more substantial than
NADH (Menon et al., 1999).
Figure 3. Schematic presentation of the de novo pathway of GDP-L-fucose and the products
obtained after chemical reduction of intermediate products of the pathway. The
intermediate products of the de novo pathway of GDP-L-fucose can be studied by reducing
them chemically with sodium borohydride (NaBH
4
). The chemical reduction of GDP-4-keto-
6-deoxy-D-mannose leads to the formation of GDP-D-rhamnose and GDP-6-deoxy-D-talose
and reduction of GDP-4-keto-6-deoxy-L-galactose leads to the formation of GDP-6-deoxy-L-
glucose and GDP-L-fucose. GMD, GDP-D-mannose 4,6-dehydratase; GMER, GDP-4-keto-6-
deoxy-D-mannose 3,5-epimerase/reductase; GDP, guanosine diphosphate.
2.4. GDP-D-mannose 4,6-dehydratase (GMD)
GMDs have been obtained at various degrees of purity from different sources, both
from bacteria like Klebsiella pneumonie (Yamamoto et al., 1993) and mammals like
porcine thyroid (Broschat et al., 1985). Cloning of the gmd gene and characterization
of the corresponding enzyme have been performed from human (Ohyama et al., 1998;
Sturla et al., 1997; Sullivan et al., 1998), Arabidopsis thaliana (known as MUR1)
(Bonin et al., 1997) and bacteria like E. coli (Sturla et al., 1997). Multimerisation of
the purified and cloned GMDs vary as well as the molecular masses of the monomers
(ca. 40-55 kDa). In general, the reported mature GMDs are homodimers consisting of
two ca. 42 kDa subunits. An amino acid sequence GILFNHES is commonly found  in
the characterized GMDs, but the possible function of this sequence is unknown.
Recently, the X-ray crystallographic structure of E. coli GMD has been determined at
2.3 Å resolution (Somoza et al., 2000). The resolved GMD structure was shown to be
a homodimeric protein with two ca. 42 kDa monomers composed of two domains
(Figure 4). The larger N-terminal domain contains the NADP(H) cofactor binding site
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in a classical Rossman fold topology consisting of seven parallel β-sheets and seven
α-helices. The smaller C-terminal domain harbors the binding site for the nucleotide
sugar substrate. This domain is predominantly composed of four β-sheets and a cluster
of three parallel α-helices. These two domains form a pocket where the cofactor and
the substrate bind, and catalysis of the reaction occurs. Both subunits are suggested to
be catalytically competent. Somoza and colleagues (2000) have also hypothesized
that the quaternary structures of GMD family is likely to be conserved, with the
exception of the some C-terminal areas that are not involved in nucleotide sugar binding
or in catalysis. The hypothesis is based on the sequence identities, which range from
40-99% among the GMD family. The dimeric structures have already been reported
for the K. pneumonie (Yamamoto et al., 1993) and human GMDs (Bisso et al., 1999).
However, the recently resolved three-dimensional structure of A. thaliana GMD (named
as MUR1) is a tetramer (Mulichak et al., 2002) and there are reports suggesting that
H. pylori GMD is also a tetramer (Wu et al., 2001) and that porcine thyroid GMD
N-terminus
N-terminus
C-terminus
C-terminus
Figure 4. Illustration of the three-dimensional structure of E. coli GMD. E. coli GMD is a
homodimeric protein, of which monomers are composed of two domains. The N-terminal,
classical Rossman fold (seven parallel β-sheets and seven α-helices), that binds the cofactor, is
illustrated in yellow, whereas the C-terminal, substrate binding domain is dark grey. The N-
and C-termini of the enzyme are indicated.
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might be a hexamer (Broschat et al., 1985) being in contradiction to the hypothesis
proposed by Somoza and colleagues (2000).
The E. coli GMD model shows that GMD is a member of a short chain dehydrogenase/
reductase (SDR) protein family. The SDR protein family is a very large family of
enzymes, most of which are known to be NADH/NADPH-dependent oxidoreductases
(Jörnvall et al., 1995). The three-dimensional structure of E. coli GMD is closely
related to the resolved homodimeric structures of E. coli GMER (Rosano et al., 2000)
and E. coli UDP-galactose 4-epimerase (GalE) (Thoden et al., 1996), both of which
are also members of the SDR protein family. GalE catalyzes the interconversion of
UDP-galactose and UDP-glucose. In addition, the GMD model and site-directed
mutagenesis studies show that the Ser-Tyr-Lys catalytic triad common to enzymes of
the SDR protein family is found in E. coli GMD, with the exception that Thr replaces
Ser. Most of GMDs have also Thr in the usual place of Ser in the catalytic triad. This
replacement of Ser to Thr is an unique feature among the SDR protein family. However,
the influence of the exchange of Ser to Thr in GMDs is not known. Somoza and
coworkers (2000) also observed that the dimerisation of GMD happens in a similar
way as has been described for the other members of SDR protein family. On the basis
of the GMD model and mutational analysis, the Glu135 is proposed to play a role in
the deprotonation/reprotonation of the mannose ring thus acting as an active-site base
during the catalysis (Somoza et al., 2000).
GDP-L-β-fucose, which is the end product of the pathway, has been demonstrated to
inhibit the activity of both human and bacterial GMD via a specific feedback inhibitory
mechanism (Bisso et al., 1999; Sturla et al., 1997). In E. coli GMD, GDP-L-β-fucose
also shows competitive inhibition in respect to GDP-D-mannose indicating that GDP-
L-β-fucose probably binds to the same site on the enzyme as GDP-D-mannose. The
competitive inhibition also indicates that GDP-L-β-fucose regulates its own
biosynthesis through the activity of GMD (Somoza et al., 2000). In contrast, GDP-L-
β-fucose shows no competitive inhibition in human GMD (Bisso et al., 1999). GDP-
L-α-fucose, an anomer of GDP-L-β-fucose, does not inhibit the activity of human and
bacterial GMD, whereas GDP-D-glucose shows an inhibitory effect (Bisso et al., 1999;
Sturla et al., 1997).
A defective synthesis of GDP-L-fucose and especially defects in GMD activity has
been linked to stem shoot development in plants (Bonin et al., 1997). Humans deficient
in fucosylation suffer from the rare immune disorder leukocytes adhesion deficiency
type II (LAD II) that is characterized by defective selectin ligand formation, recurrent
infections and severe mental and growth retardation (Becker and Lowe, 1999).
Recently, the molecular mechanism for this disorder has been located to the GDP-L-
fucose transporter gene (Etzioni et al., 2002; Luhn et al., 2001). In contrast, increased
fucosylation of glycoconjugates, e.g. increased expression of sialyl Lex or sialyl Lea
has been observed in metastasis of cancer patients (Martin-Satue et al., 1998; Ura et
al., 1997) or inflammatory diseases, such as acute transplant rejection or bronchial
asthma (Kirveskari et al., 2000; Toppila et al., 2000; Toppila et al., 1999).
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2.5. GDP-4-keto-6-deoxy-D-mannose 3,5-epimerase/reductase (GMER)
GMER was first purified from porcine thyroid (Chang et al., 1988) followed by cloning
the corresponding gene from humans (named as FX) (Tonetti et al., 1996), E. coli
(also named as Fcl/WcaG) (Tonetti et al., 1998) and A. thaliana (named as GER1)
(Bonin and Reiter, 2000). Mature human and E. coli GMERs are homodimers of two
ca. 34 kDa subunits. The monomer of A. thaliana GMER is also ca. 35 kDa, but its
possible multimerisation is unknown.
Recently, two research groups have determined by the X-ray crystallography the
structure of E. coli GMER at 2.1-2.2 Å resolution (Rizzi et al., 1998; Somers et al.,
1998). Furthermore, the comparison of the crystal structures of the native and three
mutated GMERs have been elucidated at 1.45-1.60 Å resolution (Rosano et al., 2000).
The resolved GMER structure was shown to be a homodimeric protein with each
monomer composed of two domains (Figure 5). The N-terminal domain contains
NADP(H) cofactor binding site in a modified Rossman fold topology containing six
parallel β-sheets and six α-helices. The C-terminal domain harbors the binding site
for the nucleotide sugar substrate. This domain is composed of three parallel α-helices
and two antiparallel pairs of parallel β-sheets. This GMER model shows that GMER
is a member of the SDR protein family and it is closely related to the resolved
Figure 5. Illustration of the three-dimensional structure of E. coli GMER. E. coli GMER
is a homodimeric protein, of which monomers are composed of two domains. The N-terminal,
modified Rossman fold (six parallel β-sheets and six α-helices), that binds the cofactor, is
illustrated in yellow, whereas the C-terminal, substrate binding domain is dark grey. The N-
and C-termini of the enzyme are indicated.
N-terminus
N-terminus
C-terminus
C-terminus
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homodimeric structures of E. coli GMD (Somoza et al., 2000) and E. coli GalE (Thoden
et al., 1996). Additionally, the GMER model and site-directed mutagenesis studies
show that the catalytic mechanism of GMER is based on the concerted action of Ser-
Tyr-Lys residues forming the conserved catalytic triad of the SDR protein family. The
GMER model also indicates that the GDP-4-keto-6-deoxy-D-mannose substrate might
be located in the pocket facing Ser107, Ser108, Cys109 and His179 residues thus
bringing the C4 position of the 4-ketopyranose rings close to the nicotinamide moiety
of NADPH during reduction (Rizzi et al., 1998; Rosano et al., 2000). Moreover, the
Cys109 and His179 residues are suggested to play a primary role in the epimerisation
reaction (Rosano et al., 2000).
Among the SDR protein family, the ability of GMER to catalyze two different reactions,
epimerisation and reduction, at the same active site appears unique. Furthermore, it is
not common in the NADH/NADPH-dependent SDR protein family that the
epimerisation catalyzed by GMER occurs in the absence of its cofactor NADPH
(Menon et al., 1999). The bifunctional nature of GMER also separates the GDP-L-
fucose biosynthesis from that of other deoxy or dideoxy sugars, in which the
epimerisation and reduction reactions are catalyzed by separate enzymes.
Defects in GMER activity has been linked to nodulation (Lamrabet et al., 1999;
Mergaert et al., 1997) and survival of bacteria (McGowan et al., 1998). In H. pylori,
the gmer gene (also known as wbcJ) is upregulated in response to an acidic environment.
The acid-induced upregulation suggests that an acidic pH may stimulate LPS synthesis,
which may be substantial in decreasing the host gastric acid secretion and in masking
the antigenic surface epitopes of H. pylori and thereby facilitating early colonization
(McGowan et al., 1998). Moreover, the H. pylori gmer knock-out mutant is
demonstrated to be more sensitive to acid stress than the wild-type strain suggesting
that O-antigen expression might contribute to acid survival of H. pylori (McGowan et
al., 1998).
2.6. Fucosyltransferases (FucT)
GDP-L-fucose and dTDP-D-fucose are used as substrates for specific
fucosyltransferases that are responsible for transferring L-/D-fucose at different positions
of an acceptor molecule. To date, no D-fucosyltransferases has been identified, whereas
ten human L-fucosyltransferases (FucT) responsible for α1,2-, α1,3-, α1,4-, or α1,6-
linkages on glycans (FutTs I-IX) (reviewed in de Vries et al., 2001) or O-linkage to
Ser or Thr have been identified (O-FucT-1) (Wang et al., 2001).  In addition, Roos and
colleagues (2002) have proposed candidates representing two novel human FucTs
named as FutX and FutXI. The candidates are proposed on the basis of in silico analysis
and they have not been experimentally verified. FucTs responsible for α1,2-, α1,3-,
α1,4-, or α1,6-linkages on glycans have been identified only in a limited number of
bacteria, e.g. H. pylori and some Rhizobium species (reviewed in Oriol et al., 1999;
Wang et al., 2000).
Three futT genes, i.e. two α1,3-fucTs (or α1,3/4-fucTs) and one α1,2-fucT are present
in each H. pylori isolate investigated to date (Alm et al., 1999; Rasko et al., 2000;
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Tomb et al., 1997; Wang et al., 1999). The encoded FucTs from different H. pylori
strains have varying levels of activity and different acceptor specificities.
As in mammalian cells, the synthesis of Lewis antigens in H. pylori is directed by
series of glycosyltransferases that act sequentially upon a precursor molecule. FucTs
are responsible for the final steps in this process. It has been demonstrated that the Lex
synthesis occurs similarly in H. pylori as observed in mammalian cells; L-fucose is
added to the Type II precursor LacNAc by α1,3-FucTs (Figure 6) (Chan et al., 1995).
H. pylori NCTC 11637 strain has two α1,3-FucT genes, futA and futB, encoding two
α1,3-FucTs with different specificities. Appelmelk and colleagues (1999) have
suggested that in the H. pylori NCTC 11637 strain, the futA gene product fucosylates
internal LacNAc, while the futB gene product fucosylates the terminal LacNAc of O-
antigen.
H. pylori has apparently developed unique biosynthetic pathways for the Ley and Leb
antigens (Figure 6). In the synthesis of the Ley antigen, the H type II antigen is a
normal precursor in mammals, whereas the Lex antigen is primarily used as a precursor
in H. pylori. This is consistent with the observation that H. pylori strains are not known
to express the H type II antigen (reviewed in Wang et al., 2000). However, the H.
pylori α1,3-FucTs have been demonstrated in vitro to utilize both LacNAc and H
Type II as acceptor molecules (Martin et al., 1997; Rasko et al., 2000). In the Leb
synthesis, the H Type II antigen is the normal biosynthetic precursor in mammals,
whereas in H. pylori the Lea antigen may be the primarily used precursor. The H.
pylori α1,2-FucTs have been shown to utilize monofucosylated Lewis antigens (Lex
and Lea) as acceptor molecules in the synthesis of difucosylated Lewis antigens (Ley
and Leb). On the contrary, mammalian α1,2-FucTs do not normally utilize
monofucosylated substrates. Furthermore, the H. pylori α1,2-FucTs have been
demonstrated to utilize unfucosylated acceptor molecules such as the Lec antigen and
LacNAc leading to the formation of the H Type I and Type II antigens, respectively
(Wang et al., 1999). However, as mentioned above, the H. pylori strains are not known
to express the H Type II antigen. The characterized α1,3/1,4-FucT is capable of utilizing
the Lec and H Type I antigens as acceptors in vitro, although the 1,4-FucT activity
with the H Type I antigen as a substrate is relatively weak (Rasko et al., 2000).
H. pylori and eukaryotic FucTs are highly divergent in overall amino acid sequences
and in domain structures. All the mammalian fucosyltransferases have a domain
structure containing a short N-terminal cytoplasmic tail, a transmembrane domain,
and a stem region followed by a large globular C-terminal catalytic domain. The N-
terminal cytoplasmic tail and transmembrane domain have a role in the Golgi
localization and in the retention of the enzyme. In contrast, the amino acid sequences
of H. pylori FucTs are devoid of a N-terminal transmembrane domain. The H. pylori
α1,3 FucT has been shown to be membrane associated, whereas the α1,2 FucT has
been found to be a soluble protein (reviewed in Wang et al., 2000). Oriol and collegues
(1999) have suggested that eukaryotic and prokaryotic α1,2-, α1,3- and α1,6-
fucosyltransferases might have a common ancestor or alternatively, α1,2/6-
fucosyltransferases have one common ancestor and α1,3-fucosyltransferases have a
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common ancestor of their own (Oriol et al., 1999). Furthermore, Breton and coworker
(1998) have suggested that since all fucosyltransferases utilize GDP-L-fucose as a L-
fucose donor, their specificity will probably reside in the recognition of the acceptor
and in the type of linkage formed (Breton et al., 1998). Detailed studies on H. pylori
(discussed above) and human FucTs (Niemelä et al., 1998; Toivonen et al., 2002)
support this hypothesis.
Figure 6. Biosynthesis of Lewis glycans. Panel A illustrates the biosynthesis of mono- and
difucosylated Lewis antigens from the Type I precursor and panel B illustrates the synthesis
from the Type II precursor. The only difference between the Type I and Type II precursors is
the β1,3- and β1,4-linkages of the monosaccharides in the backbone glycans, respectively.
FucT, fucosyltrasferase; Gal, galactose; Fuc, fucose; GlcNAc, N-acetyl-D-glucosamine; R, an
acceptor molecule.
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α1,3/4-fucTs genes (also known as futA/B) of H. pylori contain characteristic
polyadenine - polycytosine tracts at the 5´ end that have been identified as the cause of
DNA slippage leading to the on/off switch of the target gene at the translational level
(Appelmelk et al., 1999). The α1,3/4-fucTs genes also contain a 21-mer repeat region
at the 3´ end that may play a role in the dimerisation and translational control of the
FucT proteins (Ge et al., 1997). The α1,2-fucT gene (also named as futC) contains
similar polycytosine tract like the α1,3/4-fucTs genes as well as an adenine rich sequence
at mid-region of the gene that may be responsible for slipped strand mispairing leading
to the on/off status of α1,2-fucT. The nucleotide repeats in α1,2-fucT precede or belong
to the sequence regulating the translational frameshifting that may also be responsible
for the slipped strand mispairing (Wang et al., 1999). These cis-elements of H. pylori
fucT genes lead to the phase variation of Lewis antigens. As mentioned above, the
antigenic phase variation is most probably beneficial to H. pylori in adaptation to
different environments and environmental changes, but its role in colonization and
pathogenesis is unclear.
2.7. Genetic organization of genes related to L-fucose metabolism
In bacteria, the genes required for the synthesis of nucleotide sugars are generally
scattered within the same gene cluster for a particular bacterial polysaccharide. GDP-
L-fucose pathway genes have been reported to belong to the wb (formely named as
rfb) gene cluster that encodes O-antigen synthesis (Zhang et al., 1996) or the CA gene
cluster that encodes colanic acid synthesis (Stevenson et al., 2000). For example, in E.
coli K12, GDP-L-fucose pathway genes are located in the wca gene cluster, which is
responsible for the synthesis of the L-fucose containing EPS colanic acid
(Andrianopoulos et al., 1998). It has been suggested that similarity in the three-
dimensional structures of E. coli GMD and GMER with the observation that the
corresponding genes are adjacent to each other on the bacterial genome might be due
to a common ancestor (Somoza et al., 2000).
In H. pylori, O-antigen synthesizing genes are not clustered in one locus, as is the case
in other bacteria. Instead, only manC, the D-mannose-6-phosphate isomerase/GDP-D-
mannose pyrophosphorylase gene (also known as rfbM), gmd (also known as rfbD)
and gmer (also known as wbcJ) genes are clustered and the other genes required for
the O-antigen synthesis are distributed throughout the genome (Alm et al., 1999; Tomb
et al., 1997).  Berg and coworkers (1997) have suggested that this unusual genetic
organization in H. pylori may be due to the special feature of H. pylori – host interaction
that may favor the exchange of LPS synthesizing genes en bloc. Furthermore, the
genetic organization is also in accordance with a proposed assembly mechanism of H.
pylori O-antigen that differs from the mechanism used by other Gram-negative bacteria.
Instead of transferring subunits consisting of several monosaccharides onto the growing
O-antigen, the H. pylori O-antigen may be assembled by sequential addition of a
single monosaccharide (Berg et al., 1997; Rasko et al., 2000).
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3.1. Prevalence of rhamnose
Rhamnose is a deoxyhexose sugar found widely in bacteria and plants, but not in
humans. Of the two isomers, L and D, the former is much more common. L-rhamnose
is found in a wide variety of both Gram-negative and Gram-positive bacteria, in which
it is a common component of cell wall and capsule structures. The widespread
prevalence of L-rhamnose and its relevance for several clinically significant pathogens
has made the biosynthetic pathway of L-rhamnose an appealing target for novel
therapeutic interventions. Humans neither synthesize nor utilize L-rhamnose (reviewed
in Giraud and Naismith, 2000).
The activated nucleotide sugar form of L-rhamnose is dTDP-L-rhamnose, which is
synthesized from glucose-1-phosphate and deoxythymidine triphosphate (dTTP) via
a biosynthetic pathway requiring four enzymes (Figure 2). The first enzyme in the
pathway is glucose-1-phosphate thymidylyltransferase (RmlA, EC 2.7.7.24), which
catalyzes the transfer of a thymidylmonophosphate nucleotide to glucose-1-phosphate.
The catalytic activity of RmlA is most likely regulated by the end product of the
pathway, dTDP-L-rhamnose (Blankenfeldt et al., 2000). A similar specific feedback
inhibitory mechanism has also been detected in the biosynthetic pathways of GDP-L-
fucose (Sturla et al., 1997) and GDP-D-mannose (Wu et al., 2002).
The second enzyme dTDP-D-glucose 4,6-dehydratase (RmlB, EC 4.2.1.46) catalyzes
an oxidation of the C4 hydroxyl group of the D-glucose residue that is followed by
dehydratation, which leads to the formation of dTDP-4-keto-6-deoxy-D-glucose.
Mechanistically, the catalytic action of RmlB is closely related to that of GMD (Allard
et al., 2001; Allard et al., 2000; Somoza et al., 2000).
The third enzyme dTDP-4-keto-6-deoxy-D-glucose 3,5-epimerase (RmlC, EC 5.1.3.13)
catalyzes a double epimerisation reaction at the C3 and C5 positions of the 4-keto-6-
deoxy-D-glucose ring (Graninger et al., 1999). GMER also catalyzes a double
epimerisation at positions C3 and C5 of the 4-keto-6-deoxy-D-mannose ring, but RmlC
shows no structural similarity to GMER (Christendat et al., 2000; Giraud et al., 2000;
Rosano et al., 2000). The cofactor (NADPH) and the sugar nucleotide binding sites of
GMER have no counterpart in RmlC and thereby Giraud and colleagues (2000) have
suggested that the mechanisms of epimerization are likely to be different in these
enzymes.
Finally, in the synthesis of dTDP-L-rhamnose the fourth enzyme is dTDP-4-keto-6-
deoxy-L-mannose reductase (RmlD, EC 1.1.1.133), which reduces the C4 keto group
of the 4-keto-6-deoxy-L-mannose moiety and leads to the formation of dTDP-L-
rhamnose (Graninger et al., 1999). RmlD shares sequence homology with GalE, GMD,
and GMER in those amino acids known to have catalytic function (Blankenfeldt et
al., 2002; Rosano et al., 2000; Somoza et al., 2000; Thoden et al., 1996). RmlD also
shares amino acid homology with its direct analogue a GDP-4-keto-6-deoxy-D-mannose
3. D-RHAMNOSE PATHWAY
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reductase (RMD) involved in the synthesis of GDP-D-rhamnose (Kneidinger et al.,
2001). The RmlA-D enzymes are highly conserved among microorganisms and their
three-dimensional structures have been resolved (Allard et al., 2001; Allard et al.,
2000; Blankenfeldt et al., 2000; Blankenfeldt et al., 2002; Christendat et al., 2000;
Giraud et al., 2000). The genes encoding the RmlA-D enzymes are located in the wb
(formely known as rfb) gene cluster together with genes required for the assembly of
the particular bacterial polysaccharide. However, the four rml genes may not necessarily
be clustered next to each other (reviewed in Giraud and Naismith, 2000).
D-rhamnose, the enantiomer of L-rhamnose, is not a very common 6-deoxyhexose.
Hitherto, it has mainly been found as a constituent of EPS or LPS of Gram-negative
bacteria, such as plant pathogens, e.g. P. syringae (Ovod et al., 1996) and Xanthomonas
campestris (Molinaro et al., 2003) and human pathogens, e.g. P. aeruginosa (Yokota
et al., 1987), C. fetus (Senchenkova et al., 1996), H. pylori (Kocharova et al., 2000),
Burkholderia cepacia (Cerantola and Montrozier, 1997), and Stenotrophomonas
maltophilia (Winn and Wilkinson, 1998). In H. pylori, the D-rhamnose residues
containing O-antigen is atypical and it is only detected in some Danish strains, which
are nontypeable with antibodies against Lewis and other blood group determinants
(Kocharova et al., 2000). The biosynthesis of GDP-D-rhamnose (Figure 7) is described
in detail in section 3.3.
3.2. D-rhamnose in P. aeruginosa LPS
P. aeruginosa is a natural soil inhabitant with a very versatile metabolic potential
permitting it to be able to survive in a number of environments. It is also a human
opportunistic pathogen infecting mainly immunocompromised patients and causing a
range of severe infections. A new clinical problem is the rapidly increasing resistance
of P. aeruginosa against commonly used antibacterial drugs (Kiska and Gilligan, 1999).
Hence, the virulence factors and the pathogenesis of P. aeruginosa have recently gained
much interest. P. aeruginosa LPS plays an important role in the virulence of this
ubiquitous bacterium. P. aeruginosa synthesizes concomitantly two chemically and
antigenically distinct forms of O-antigen, known as a common A-band and a serotype-
specific B-band (reviewed in Rocchetta et al., 1999). The A-band O-antigen is a
homopolymer consisting of D-rhamnose sugar residues arranged as repeating
trisaccharide units (->3D-Rhaα1->2D-Rhaα1->3D-Rhaα1->)
n
 (Arsenault et al., 1991).
In contrast, the B-band O-antigen is a heteropolymer composed of repeating di- to
pentasaccharide units of many different monosaccharides (Knirel and Kochetkov,
1994). The constitutively expressed A-band O-antigen is shorter and neutrally charged
and, in the absence of the B-band LPS, confers hydrophobic properties upon P.
aeruginosa (Arsenault et al., 1991; Lam et al., 1989). The B-band O-antigen is highly
anionic and has more O-antigen repeat units than the A-band O-antigen thereby masking
it (Lam et al., 1989). The B-band O-antigen has been shown to impede phagocytosis
and is responsible for resistance to host serum (Engels et al., 1985). D-rhamnose is
found only in the A-band O-antigen, while L-rhamnose is found in the core
oligosaccharide (Rahim et al., 2000), B-band O-antigen and rhamnolipids of P.
aeruginosa (reviewed in Maier and Soberon-Chavez, 2000; Rocchetta et al., 1999).
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The gene clusters responsible for the synthesis of A- and B-band band LPS have been
identified and their genetics and regulatory mechanisms as well as their relevance to
the pathogenesis of P. aeruginosa are under extensive study. The availability of the
whole genome sequence of P. aeruginosa has contributed to these studies (Stover et
al., 2000). On the basis of mutagenesis studies, it has been proposed that in the A-
band gene cluster the function of open reading frame (ORF) after the gmd gene could
be involved in the synthesis of GDP-D-rhamnose (Rocchetta et al., 1998).
P. aeruginosa is commonly isolated from the specimens obtained from the lungs of
patients suffering the congenital monogenic disease cystic fibrosis (CF). The respiratory
P. aeruginosa isolates from the chronic CF infection are devoid of O-antigen or mainly
express the D-rhamnosylated A-band O-antigen (reviewed in Lyczak et al., 2002;
Rocchetta et al., 1999). Hitherto, no specific condition has been identified to influence
the synthesis or regulation of A-band LPS. Interestingly, exactly the same D-rhamnan
polysaccharide structure as observed in the A-band LPS of P. aeruginosa has also
been found from the other opportunistic pathogens B. cepacia and S. maltophilia also
associated with the CF disease with severe pulmonary manifestation (Cerantola and
Montrozier, 1997; LiPuma, 2000; Winn and Wilkinson, 1998). In addition, B. cepacia
and S. maltophilia have also emerged as important multidrug resistant pathogens and
a cause of nosocomial infections (reviewed in Mahenthiralingam et al., 2002; Zhang
et al., 2000).
3.3. GDP-D-rhamnose metabolism
Markovitz proposed a biosynthetic pathway for GDP-D-rhamnose in the 1960s
(Markovitz, 1964). Recently, Kneidinger and colleagues (2001) provided evidence
for the proposal by cloning the enzymes required for the synthesis of GDP-D-rhamnose.
The GDP-D-rhamnose pathway starts from GDP-D-mannose (Figure 7), which is
converted into GDP-4-keto-6-deoxy-D-mannose by GMD, as is the case in the synthesis
of GDP-L-fucose (Figure 3). The following step in the GDP-D-rhamnose pathway is
the specific reduction of the 4-keto group of GDP-4-keto-6-deoxy-D-mannose, which
leads to formation of GDP-D-rhamnose, and which is catalyzed by GDP-4-keto-6-
deoxy-D-mannose reductase (RMD) (EC 1.1.1.187). During the action of reduction
RMD can utilize either NADH or NADPH as hydride donors. The reduction activity
of RMD is analogous to the activity of the RmlD enzyme, which is responsible for the
reduction of the C4 keto group of dTDP-4-keto-6-deoxy-L-mannose in the synthesis
of dTDP-L-rhamnose (Giraud et al., 1999). Kneidinger and colleagues (2001) identified
two enzymes, GMD and RMD, responsible for the GDP-4-keto-6-deoxy-D-mannose
reductase activity from the non-pathogenic, Gram-positive A. thermoaerophilus L420-
91T bacterium. D-rhamnose is a constituent of the surface layer glycoprotein of this
bacterium. The specific function of D-rhamnosylated S-layer of A. thermoaerophilus
L420-91T is unknown.
3.4. GDP-4-keto-6-deoxy-D-mannose reductase
A. thermoaerophilus GMD has been shown to be a bifunctional enzyme with both
GDP-mannose 4,6-dehydratase and GDP-4-keto-6-deoxy-D-mannose reductase
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activity, however the latter activity is relatively weak in comparison to the activity of
A. thermoaerophilus RMD acting only as a reductase (Kneidinger et al., 2001). The
amino acid residues reported to be important for the catalysis of the dehydratase reaction
or for the binding of NADP cofactor or GDP-D-mannose substrate in E. coli GMD
(Somoza et al., 2000) are also found in A. thermoaerophilus GMD, with the exception
that in the catalytic triad (Thr-Tyr-Lys) Thr replaces Ser. The catalytic triad Ser-Tyr-
Lys is more common among the enzymes belonging to the SDR protein family than a
triad consisting of Thr-Tyr-Lys (Jörnvall et al., 1995), which is hitherto observed only
in GMDs (Somoza et al., 2000). The amino acid sequence GILFNHES, which appears
to be characteristic of GMDs (Somoza et al., 2000), is also found in A. thermoaerophilus
GMD. The molecular mass of the monomer of A. thermoaerophilus GMD is ca. 37
kDa, whereas possible multimerisation of the enzyme is unknown. To date, A.
thermoaerophilus GMD is the only enzyme identified to catalyze both dehydratase
and reductase reactions. A possible explanation for the bifunctional nature of A.
thermoaerophilus GMD could be mutations in the gmd gene (Kneidinger et al., 2001).
Genes encoding enzymes involved in the synthesis of nucleotide sugars are usually
found in the gene cluster for the particular bacterial polysaccharide. In the genome of
A. thermoaerophilus, rmd is located directly downstream of gmd. The characterized
A. thermoaerophilus RMD acts only as a GDP-4-keto-6-deoxy-D-mannose reductase
in the synthesis of GDP-D-rhamnose. The molecular mass of the monomer of RMD is
ca. 35 kDa, whereas the possible multimerisation of the enzyme is unknown. The
amino acid sequence of RMD contains an N-terminal coenzyme-binding pattern
GlyXXGlyXXGly, and an active-site Ser-Tyr-Lys triad common to the SDR protein
family. Other residues involved in GMD catalysis (Somoza et al., 2000), with the
exception of Glu135 are not found in RMD (Kneidinger et al., 2001). In GMD catalysis,
Figure 7. Schematic presentation of the biosynthetic pathways of GDP-D-rhamnose and
GDP-6-deoxy-D-talose. GMD, GDP-D-mannose 4,6-dehydratase; RMD, GDP-4-keto-6-deoxy-
D-mannose reductase; GTS, GDP-6-deoxy-D-talose synthetase; GDP, guanosine diphosphate.
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Glu135 is proposed to play a role in the deprotonation/protonation of the hydroxyl
group of the C5 position of GDP-4-keto-6-deoxy-D-mannose (Somoza et al., 2000),
but this C5 atom is not involved in the reduction reaction catalyzed by RMD (Kneidinger
et al., 2001).
3.5. Rhamnosyltransferases
GDP-D-rhamnose and dTDP-L-rhamnose are used as substrates for specific
rhamnosyltransferases that are responsible for transferring L-/D-rhamnose to an acceptor
molecule via a specific linkage. Currently, very little is known about the bacterial
rhamnosyltransferases. L-rhamnosyltransferases, which use dTDP-L-rhamnose as a
donor, have been reported in several bacteria (reviewed in Giraud and Naismith, 2000),
whereas putative D-rhamnosyltransferases, which use GDP-D-rhamnose as a donor,
have only been identified from P. aeruginosa (Rocchetta et al., 1998). On the basis of
mutagenesis studies it has been shown that three putative D-rhamnosyltransferases
(WbpZ, WbpY and WbpX) participate in the synthesis of the linear A-band O-antigen
in P. aeruginosa. Specific functions or detailed acceptor specificities of WbpZ, WbpY
and WbpX have not been experimentally verified. However, Rocchetta and coworkers
(1998) have proposed that in the synthesis of repeating D-rhamnan structure (->3D-
Rhaα1->2D-Rhaα1->3D-Rhaα1->)
n
 WbpZ may be responsible for transferring the
first D-rhamnose moiety to the acceptor molecule via an α1->3 linkage. The initial A-
band O-antigen acceptor molecule is probably L-rhamnose, which is also the initial B-
band O-antigen acceptor molecule (Rahim et al., 2000). WbpY may be responsible
for transferring the following two α1->3 linked D-rhamnose moieties to the first D-
rhamnose. The terminal α1->3 linked D-rhamnose would then act as an acceptor for
WbpX, which adds one D-rhamnose moiety to the A-band polymer via an α1->2
linkage. Both WbpY and WbpX would then continue to synthesize the A-band O-
antigen assuming that WbpY recognizes dual acceptors, the first α1->3 linked D-
rhamnose transferred by WbpZ and the α1->2 linked D-rhamnose transferred by WbpX.
This hypothesis is consistent with the genetic organization of the wbpX, wbpY and
wbpZ genes, which are located in the opposite order to which the encoded enzymes
act. A similar genetic arrangement coupled to the sequential order of the O-antigen
assembly has been seen with other glycosyltransferases (Kido et al., 1995).
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4.1. Prevalence of 6-deoxy-talose
6-deoxy-talose is a rare deoxyhexose sugar. To date, it is found only in bacteria. Of the
two isomers, L and D, the former is more common. 6-deoxy-L-talose is found in a few
Gram-negative and Gram-positive bacteria, in which it is a constituent of cell wall
and capsule structures. The activated nucleotide sugar form of 6-deoxy-L-talose is
dTDP-6-deoxy-L-talose, which is synthesized from glucose-1-phosphate and dTTP
via a biosynthetic pathway requiring four enzymes (Figure 2). The first three enzymes
RmlA-C are the same as in the biosynthetic pathway of dTDP-L-rhamnose. The fourth
enzyme Tll is also a dTDP-4-keto-6-deoxy-L-mannose reductase like RmlD, but the
stereoselectivity of Tll determines that dTDP-4-keto-6-deoxy-L-mannose is reduced
to dTDP-6-deoxy-L-talose (Nakano et al., 2000).
6-deoxy-D-talose is an enantiomer of 6-deoxy-L-talose. GDP-6-deoxy-D-talose is an
activated nucleotide sugar form of 6-deoxy-D-talose, which has been found only in
EPS or LPS structures of a limited number of Gram-negative bacteria, such as A.
actinomycetemcomitans serotype a and Burkholderia (Pseudomonas) plantarii strain
DSM 6535 (Shibuya et al., 1991; Weckesser et al., 1973; Zähringer et al., 1997). The
biosynthesis of GDP-6-deoxy-D-talose (Figure 7) is decribed in detail in section 4.3.
4.2. 6-deoxy-D-talose in A. actinomycetemcomitans LPS
An O-acetylated, linear homopolysaccharide of 6-deoxy-D-talose has been found in
the serotype a-specific polysaccharide antigen (SPA) of A. actinomycetemcomitans
(Perry et al., 1996; Shibuya et al., 1991) and the EPS of the B. plantarii strain DSM
6535 (Zähringer et al., 1997). The 6-deoxy-D-talan polymer of A.
actinomycetemcomitans serotype a is composed of repeating disaccharide units (->3
6dTalα1->2 6dTalα1->)
n
, whereas 6-deoxy-D-talan of B. plantarii strain DSM 6535
is composed of repeating trisaccharide units (->3 6dTalα1->2 6dTalα1->2 6dTalα1-
>)
n
. Both 6-deoxy-D-talan polymers are acetylated at the O2 position of α1->3 linked
6-deoxy-D-talose. The specific roles of 6-deoxy-D-talan O-polysaccharide (O-PS) of
human opportunistic pathogen A. actinomycetemcomitans serotype a and 6-deoxy-D-
talan EPS of plant pathogen B. plantarii strain DSM 6535 are unknown. In general,
bacterial extracellular polysaccharides consisting of only one type of 6-deoxyhexose
are rare. D-rhamnans and L-rhamnans are found in several bacteria, e.g. P. aeruginosa
(Arsenault et al., 1991) and Bacillus stearothermophilus strain NRS 2004/3a (Christian
et al., 1986), respectively. 6-deoxy-L-talans are found in the SPA of A.
actinomycetemcomitans serotype c (Perry et al., 1996) and Rhizobium loti NZP2213
(Russa et al., 1995), and homopolymers of 6-deoxy-L-altrose are found in Y.
enterocolitica O:3 (Hoffman et al., 1980) and Pectinatus frisingensis (Senchenkova
et al., 1995).
In addition to 6-deoxy-D-talose and 6-deoxy-L-talose, other deoxyhexoses such as L-
rhamnose and D-fucose are found in different SPAs of A. actinomycetemcomitans
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(Amano et al., 1989; Perry et al., 1996). A. actinomycetemcomitans is a coccobacillus
that colonizes the human oral cavity and has been implicated in the etiology of localized
juvenile periodontitis (LJP), adult periodontitis and severe nonoral infections (reviewed
in Henderson et al., 2002). The serologic specificity of A. actinomycetemcomitans
strains is defined by 6 structurally and antigenically distinct O-PS components of
their respective LPS (Gmur et al., 1993; Kaplan et al., 2001; Saarela et al., 1992).
These serotype specific polysaccharides (a-f) constitute the outermost surface of the
bacterium and have thus been suggested to play a role in the virulence of A.
actinomycetemcomitans (reviewed in Fives-Taylor et al., 2000).  6-deoxy-D-talan
containing A. actinomycetemcomitans serotype a strain has been isolated from healthy
subjects as well as patients with LJP or adult perodontitis (Zambon et al., 1983). The
gene cluster associated with the biosynthesis of 6-deoxy-D-talan SPA of A.
actinomycetemcomitans SUNYaB 75 has been identified (Suzuki et al., 2000) and it
contains 14 ORFs, 9 of which were not found in SPA-associated gene clusters of the
other serotypes. Furthermore, the serotype a-SPA associated gene cluster is located in
the different region of the chromosome than the other SPA associated gene clusters
(Kaplan et al., 2001).
4.3. GDP-6-deoxy-D-talose metabolism
Markovitz proposed the biosynthetic pathway of GDP-6-deoxy-D-talose in 1960s,
although the corresponding enzymes were not specifically identified (Markovitz, 1964).
Like the other two GDP-6-deoxyhexose pathways introduced above in sections 2.3
and 3.3, the GDP-6-deoxy-D-talose pathway starts from GDP-D-mannose, which is
converted into GDP-4-keto-6-deoxy-D-mannose by GMD (Figure 7). The following
step in the GDP-6-deoxy-D-talose pathway is the specific reduction of the 4-keto group
of GDP-4-keto-6-deoxy-D-mannose, which leads to the formation of GDP-6-deoxy-
D-talose. 6-deoxy-D-talose is an epimer of D-rhamnose and differs from it only in the
orientation of the hydroxyl group at the C4 position (Figure 7). The stereoselectivity
of GDP-4-keto-6-deoxy-D-mannose reductase determines which one of these two
epimers is synthesized. The characterization of GDP-4-keto-6-deoxy-D-mannose
reductase responsible for the synthesis of GDP-6-deoxy-D-talose is described in this
study. Other enzymes related to talosylation, e.g. deoxytalosyltransferases, as well as
the regulatory mechanisms of talosylation remain to be elucidated.
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Bacterial cell surface polysaccharides have important roles in the interplay between
environment and bacteria, especially in interplay between host and pathogen. The
biosynthesis of cell surface glycoconjugates involves specific glycosyltransferases
utilizing nucleotide sugars as activated donors. The alteration of cellular nucleotide
sugar levels enables manipulation of bacterial cell surface polysaccharides. Hence,
enzymes involved only in the biosynthesis of bacterial nucleotide sugars could be
considered as potential targets for antimicrobial therapeutics. However, more detailed
studies are needed to fully understand the enzymology related to bacterial nucleotide
sugar metabolism.
Nucleotide sugars GDP-L-fucose, GDP-D-rhamnose, and GDP-6-deoxy-D-talose are
converted from GDP-D-mannose by specific enzymes. The principal goals of this
study were:
- to clone and characterize bacterial enzymes involved in the conversion of GDP-D-
mannose into GDP-deoxyhexoses
- to develop of an ion-pair reversed-phase HPLC method for the study of
synthesized nucleotide sugars
5. AIMS OF THE STUDY
33
Bacterial and yeast strains and plasmids used in this study are listed in Table 3 and 4.
The methods used in this study are described in detail in the indicated articles and are
summarized in Table 5.
Table 3. Bacterial and yeast strains used in this study
Strain Characteristicsa Article Reference
E. coli XL1Blue I
E. coli TOP10 F- mcrA ∆(mrr-hsdRMS-mcrBC) II, IV Invitrogen,Inc.
Φ80lacZ∆M15 ∆lacX74 deoR recA1
 araD139 ∆(ara-leu)7697 galU galK
 rpsL(StrR) endA1 nupG
E. coli BL21(DE3) B F- dcm ompT hsdS(rB- mB-) gal IV
H. pylori NCTC 11637 I ATCC 43504
P. aeruginosa II, III ATCC 27853
A. actinomycetemcomitans Serotype a IV ATCC 29523
S. cerevisiae YPH501 ura3-52 lys2-801amber ade2-101ochre trp1- I, II, III Invitrogen,Inc.
-∆63 his3-∆200 leu2-∆1, mating type a/α
a(Sambrook and Russell, 2001)
Table 4. Plasmids used in this study
Plasmid Relevant property Reference
pESC-LEU S. cerevisiae expression vector Stratagene,Inc.
pHP1 pESC-LEU derivate containing the H. pylori gmd gene I, II, III
as a 1143 bp fragment under the GAL10 promoter
pHP2 pESC-LEU derivate containing the H. pylori gmer gene I
as a 952 bp fragment under the GAL10 promoter
pHP3 pESC-LEU derivate containing the H. pylori gmd gene I, III
under the GAL10 promoter and the H. pylori gmer gene
under the GAL10 promoter
pRHA1 pESC-LEU derivate containing the P. aeruginosa rmd gene II
as a 915 bp fragment under the GAL1 promoter
pRHA2 pESC-LEU derivate containing the H. pylori gmd gene II, III
under the GAL10 promoter and the P. aeruginosa rmd gene
under the GAL1 promoter
pCR-XL-TOPO E. coli cloning vector Invitrogen, Inc.
pASK-IBA5 E. coli expression vector IBA, GmbH.
pKETO pASK-IBA5 derivate containing the H. pylori gmd gene IV
as a 1143 bp fragment under the tet promoter
pTAL pASK-IBA5 derivate containing the A. actinomycetemcomitans gts IV
gene as a 885 bp fragment under the tet promoter
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Table 5. Methods used in this study
Method Described and used in
Culture conditions
H. pylori I
P. aeruginosa II
A. actinomycetemcomitans IV
S. cerevisiae I, II
Genetic methods
Isolation of chromosomal DNA I, II, IV
Molecular cloning techniques I, II, IV
Sequence analysis I, II
Protein methods
Expression of fusion proteins I, II, IV
Affinity chromatography IV
Sequence analysis I, II, IV
Immunological methods
Western blot I, II
Enzyme assays
Fucosyltransferase assay I
Enzymatic reactions I, II, III, IV
Methods of carbohydrate chemistry
DEAE anion exchange I, II, III
Solid-phase extraction III, IV
Ion-pair reversed-phase HPLC I, II, III, IV
MALDI-TOF Mass spectrometry II, III, IV
NMR II, III, IV
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7.1. H. pylori GDP-L-fucose synthesizing enzymes GMD and GMER (I)
7.1.1. Functional cloning of GMD and GMER (I)
H. pylori ORFs of GMD and GMER were identified by the amino acid sequence
similarities with the corresponding E. coli enzymes and by the annotations of the
whole genome sequences of H. pylori 26695 (Tomb et al., 1997) and J99 (Alm et al.,
1999). In the genomic databases of H. pylori, HP0044 ORF was annotated as putative
GMD and HP0045 ORF was annotated as putative nodulation protein or GMER. The
identified gmd and gmer genes were amplified from the H. pylori NCTC 11637
chromosomal DNA. The 1143 base pairs (bp) gmd gene was inserted under the galactose
inducible GAL1 promoter of the yeast expression vector pESC-LEU in-frame with
the N-terminal c-myc epitope. And the 952 bp gmer gene was inserted under the
galactose inducible GAL10 promoter of the pESC-LEU vector in-frame with the N-
terminal FLAG epitope. Furthermore, a construct containing both genes with the same
N-terminal epitopes as above was prepared. Resulting plasmids pHP1, pHP2 and pHP3,
respectively, were used for overexpression of the fusion proteins in S. cerevisiae
YPH501 (Table 1). The heterologous expression of GMD and GMER was studied by
Western blotting with antibodies against the N-terminal epitopes.
The expression of ca. 44 kDa c-myc tagged GMD was detected with the c-myc antibody
from the lysates of the yeast strains harboring either the gmd gene containing pHP1
plasmid or the gmd and gmer genes containing pHP3 plasmid (Figure 3 of article I,
lanes 2 and 3). The expression of ca. 35 kDa FLAG tagged GMER was detected with
the FLAG antibody from the lysates of the yeast strains harboring either the gmer
gene containing pHP2 plasmid or the pHP3 plasmid (Figure 3/I, lanes 2 and 3). The
apparent sizes of recombinant GMD and GMER corresponded to those calculated
from the amino acid sequences. In addition to GMD and GMER, several other bands
were detected in the Western blots probably due to degradation or different glycosylation
of the recombinant proteins. However, corresponding bands were not detected from
the vector control (Figure 3/I, lane 4).
7.1.2. Enzymatic activities of recombinant GMD and GMER (I)
In order to analyze functional activities of heterologously expressed GMD and GMER,
a thorough analysis of the cellular sugar nucleotide pool of the recombinant yeast
strains was performed. GMD was expected to utilize endogenous GDP-D-mannose of
yeast as a substrate. Synthesized nucleotide sugars were analyzed by ion-pair reversed
phase high-pressure liquid chromatography (HPLC) and by fucosyltransferase assay
developed in our laboratory (III, Räbinä et al., 2000). In HPLC analysis, the cellular
GDP-sugars were identified based on the retention times of commercially available
GDP-sugar standards. Prior to HPLC analysis, the yeast lysates were purified with
solid-phase extraction (SPE) and treated with alkaline phosphatase in order to avoid
7. RESULTS AND DISCUSSION
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nucleotide peaks in the HPLC chromatograms. The methodological development of
this new sample preparation technique and ion-pair reversed-phase HPLC for the
analysis of nucleotide sugars is described in detail in section 7.3 (III).
The HPLC analysis (Figure 4/I) showed that the lysate of S. cerevisiae YPH501(pHP3)
strain co-expressing GMD and GMER gave a peak with the same retention time as the
commercial GDP-L-fucose standard (Figure 4/I, panel D). This peak was not detected
from the cytoplasmic extracts of the vector control strain or yeast strains expressing
only one of these two enzymes (Figure 4/I, panels A-C). Instead, a novel peak with
different retention time as GDP-L-fucose was detected from the lysate of S. cerevisiae
YPH501(pHP1) strain expressing only GMD (Figure 4/I, panel B). This peak
represented the intermediate product GDP-4-keto-6-deoxy-D-mannose. At the time of
the experiment, this data could not be confirmed because of the lack of an available
standard for this GDP-sugar. But with the present knowledge and available standard
isolated from the cytoplasmic extract of P. aeruginosa, this data has been confirmed.
In addition to these novel peaks that indicated the functional activities of GMD and
GMER, some uncharacterized peaks from yeast cells were detected (Figure 4/I).
 The quantity of GDP-L-fucose produced by the recombinant yeast strains was studied
with a functional fucosyltransferase assay, in which an α1,3-fucosylated glycan is
synthesized in the presence of human α1,3-fucosyltransferase VI and the fucose donor
present in the recombinant yeast strain (Figure 5/I). In this assay, the limiting factor in
the generation of fucosylated glycan is the presence or absence of GDP-L-fucose
because the relevant acceptor molecule and transferase enzyme are always present.
The detection of synthesized fucosylated glycans is based on specific antibodies and
time-resolved immunofluorometry (Räbinä et al., 2000). The results of this assay were
consistent with the results obtained from HPLC analysis (Figure 4/I). Only the S.
cerevisiae YPH501(pHP3) strain expressing both GMD and GMER was able to
synthesize GDP-L-fucose and could be used as a source of GDP-β-L-fucose (Figure 5/
I, panel B). The amount of GDP-L-fucose synthesized by the S. cerevisiae
YPH501(pHP3) strain was determined to be 5 mmol/ml of the yeast culture (Figure 5/
I, panel A).
The functional activities of H. pylori GMD and GMER were also confirmed by the
independent cloning and characterization of HP0044 and HP0045 ORFs of H. pylori
26695 by Wu and colleagues (2001). Mutagenesis studies and analysis of whole genome
sequences of H. pylori have shown that gmd and gmer are present as a single copy in
the genome thus being responsible for all fucosylation in the bacterium (Alm et al.,
1999; McGowan et al., 1998; Tomb et al., 1997).  The amino acid sequences of GMD
and GMER contained the characteristics of the SDR protein family (Jörnvall et al.,
1995) and the proposed catalytic triad of GMD contained the amino acids Thr-Tyr-
Lys like most of GMDs (Somoza et al., 2000).
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7.1.3. Synthesis of GDP-L-fucose in S. cerevisiae expression system (I)
In addition to the characterization of enzymatic activities of H. pylori GMD and GMER,
this study showed that the  S. cerevisiae expression system is applicable to the functional
expression of bacterial genes synthesizing GDP-L-fucose from yeast endogenous GDP-
D-mannose. In our laboratory, E. coli GMD and GMER have also been expressed
functionally in the same expression system (Mattila et al., 2000). The concentrations
of yeast endogenous GDP-D-mannose, NADP+ and NADPH seem apparently to be
adequate for the relatively effective production of GDP-L-fucose by recombinant
bacterial enzymes. This offers a major advantage over other expression systems as no
exogenous expensive GDP-D-mannose or cofactors need to be added to the reaction
mixture with GMD and GMER. Furthermore, S. cerevisiae appears to be an ideal host
for expressing enzymes needed for the synthesis of the deoxyhexose sugar nucleotides
because its glycosylation is largely restricted to mannosylation and it is not known to
have deoxyhexose metabolism of its own (Hashimoto et al., 1997; reviewed in Romanos
et al., 1992). The quantity of GDP-L-fucose synthesized by recombinant H. pylori
GMD and GMER was equivalent to the quantity obtained in the corresponding
recombinant enzymes of E. coli (Mattila et al., 2000). Mattila and colleagues (2000)
also showed that in this expression system the concentration of endogenous yeast
GDP-D-mannose was the limiting factor for the synthesis of GDP-L-fucose. In yeast
cells, GDP-D-mannose is synthesized in the cytoplasm and then transported to the
Golgi apparatus (Abe et al., 1999). Hence, as an expression host it might be beneficial
to use a mutant yeast strain, which has a defect in its GDP-D-mannose transportation
system. Defects in this transportation system might lead to an accumulation of sytosolic
GDP-D-mannose thus providing increased substrate concentration for GMD. However,
the synthesis of GDP-D-mannose may be regulated by a similar feedback inhibitory
mechanism as detected in the case of other nucleotide sugars, e.g. GDP-L-fucose and
dTDP-L-rhamnose (Sturla et al., 1997; Blankenfeldt et al., 2000) or in the synthesis of
GDP-D-mannose in H. pylori (Wu et al., 2002). The feedback inhibition mechanism
might prevent the accumulation of sytosolic GDP-D-mannose in abundance.
7.1.4. Conservation of GMD and GMER homologs among bacteria (I)
The synthesis of GDP-L-fucose requires the activity of both gmd and gmer genes. The
nucleotide and protein databases were searched against the sequence similarities of
known GMDs and GMERs. At the time of the experiment, the number of bacteria
having both gmd and gmer homologues was found to be relatively low (Table 1/I).
Among them were H. pylori, E. coli, Y. enterocolitica, R. fredii, Salmonella
typhimurium, Vibrio cholerae, and Mycobacterium tuberculosis. It was thought that
this might indicate that unlike among higher eukaryotes, the ability of bacteria to
fucosylate their glycans is not a very common feature. On the other hand, the number
of bacteria having both gmd and gmer homologues may increase as the number of
completely sequenced microbial genomes multiplies, for instance at present in addition
to the bacteria listed above both gmd and gmer homologues can be found in Y. pestis,
S. enterica serovar Typhi CT18 and Shigella flexneri 2a (Jin et al., 2002; Parkhill et
38
al., 2001; Parkhill et al., 2001). Hence, the ability of bacteria to fucosylate their glycans
might indeed be a common feature and not be as rare as thought above. The phylogenetic
analysis of the found bacterial gmd and gmer genes (Table 1/I) showed that the overall
identity and similarity within the sequences of the gmer gene family was clearly lower
(25% – 56%) in comparison to the gmd gene family (45% – 75%).
7.2. P. aeruginosa GDP-D-rhamnose synthesizing enzyme RMD (II)
7.2.1. Functional expression of RMD (II)
The complete rmd gene was identified from the A-band gene cluster of P. aeruginosa
by sequence analysis tools available in the GCG package (Wisconsin Package, version
10.0; Genetics Computer Group, Madison, Wisconsin, USA) and by the annotation of
PA5454 ORF of the whole genome sequence of P. aeruginosa (Stover et al., 2000).
The size of the rmd gene was 915 bp and the starting codon was found to be TTG.
Mutagenesis studies and analysis of whole genome sequences of P. aeruginosa have
shown that rmd is present as a single copy in the genome thus it is responsible for all
D-rhamnosylation in the bacterium (Rocchetta et al., 1998; Stover et al., 2000). The
rmd gene was amplified from the P. aeruginosa chromosomal DNA and subcloned
under the GAL10 promoter of the pESC-LEU vector in-frame with the N-terminal
FLAG epitope. Because the characterized H. pylori GMD was needed to generate the
GDP-4-keto-6-deoxy-D-mannose substrate for RMD, rmd was also subcloned into
the same site of pHP1 construct, which is a pESC-LEU derivate containing H. pylori
gmd (I). The resulting plasmids pRHA1 and pRHA2, respectively, and the pHP1
construct were used for overexpression of the fusion proteins in S. cerevisiae YPH501
(Table 1). The heterologous expression of GMD and RMD was studied by Western
blotting with antibodies against the N-terminal epitopes.
The expression of ca. 44 kDa c-myc tagged GMD was detected with the c-myc antibody
from the lysates of yeast strains harboring either the gmd gene containing pHP1 plasmid
or the gmd and rmd genes containing pRHA2 plasmid (Figure 3/II, lanes 2 and 4). The
expression of ca. 34 kDa FLAG tagged RMD was detected with the FLAG antibody
from the yeast lysates harboring the rmd gene containing pRHA1 plasmid or the pRHA2
plasmid (Figure 3/II, lanes 3 and 4). The apparent size of recombinant RMD
corresponded to that calculated from the amino acid sequences. In addition to GMD
and RMD, several other bands were detected in the Western blots, as was the case
with the Western blots of GMD and GMER in the previous study (Figure 3/I). These
bands were probably due to degradation or different glycosylation of GMD and RMD.
However, corresponding bands were not detected from the vector control (Figure 3/II,
lane 1).
7.2.2. Enzymatic activity of recombinant RMD (II)
To analyze functional activities of heterologously expressed GMD and RMD, a
thorough analysis of sugar nucleotides formed in reactions of recombinant S. cerevisiae
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lysates with exogenously added GDP-D-mannose and NADP+ and NADPH was
performed. The sugar nucleotides from yeast lysates were analyzed with ion-pair
reversed-phase HPLC (III), matrix-assisted laser desorption/ionization time-of-flight
mass spectrometry (MALDI-TOF MS) and 1H nuclear magnetic resonance (NMR).
The HPLC analysis (Figure 4/II) showed that the lysate of S. cerevisiae YPH501(pHP1)
strain expressing GMD gave a similar peak profile containing GDP-D-mannose and
GDP-4-keto-6-deoxy-D-mannose (Figure 4/II, panel C) as seen in the HPLC profile
of the same strain in Figure 4/I, panel B. As no standard was available for the GDP-4-
keto-6-deoxy-D-mannose intermediate product, the presence of GDP-4-keto-6-deoxy-
D-mannose in reaction mixture was studied by chemical reduction with NaBH4. After
chemical reduction, two new peaks, GDP-D-rhamnose and GDP-6-deoxy-D-talose,
were detected with HPLC (data not shown). At the time of the experiment, the GDP-
6-deoxy-D-talose peak could not be confirmed because of the lack of an available
standard for this GDP-sugar. However, with the present knowledge and the available
standard for this GDP-sugar (IV), this data has been confirmed. The GDP-4-keto-6-D-
deoxy-mannose peak was not detected from the lysate of the S. cerevisiae
YPH501(pRHA2) strain co-expressing GMD and RMD. Instead, a novel peak with a
retention time different from that of GDP-4-keto-6-deoxy-D-mannose or any other
GDP-sugar standard was detected (Figure 4/II, panel D). This peak was further analyzed
by MALDI-TOF MS. MALDI-TOF MS analysis gave a single peak at m/z 588.05,
which is the mass of the GDP-deoxyhexoses (calculated m/z for [M-H]– is 588.08).
The novel GDP-deoxyhexose peak together with the GDP-4-keto-6-deoxy-D-mannose
peak was also seen when the lysates of yeast strains expressing either GMD or RMD
were mixed together (Figure 4/II, panel E). The peaks of interest were not detected
from the HPLC chromatograms of the vector control strain or the yeast strain expressing
RMD (Figure 4/II, panel A-B). In addition to the peaks that indicated the functional
activities of GMD and RMD, some uncharacterized peaks from yeast cells were
detected (Figure 4/I). The addition of NADPH as a cofactor was required for the
RMD activity.
To establish the structure of the novel GDP-deoxyhexose, it was analyzed by 1H NMR
spectroscopy. The 1H NMR spectrum of the novel GDP-deoxyhexose was assigned
(Figure 5/II) and the proton-proton coupling constants 3JH,H (Table 2/II) were determined
from a DQFCOSY spectrum (data not shown). The NMR results established the
structure as GDP-rhamnose with the characteristic presence of a methyl group bound
to the carbon atom 5. The coupling constants between the ring protons of the rhamnosyl
unit were characteristic of a mannoconfiguration and clearly distinguished the structure
from GDP-L-fucose. The chemical shifts obtained were similar to those published by
Kneidinger and colleagues (2001) for GDP-D-rhamnose and different from those
reported for GDP-L-fucose (Adelhorst and Whitesides, 1993).
7.2.3. Synthesis of GDP-D-rhamnose in S. cerevisiae expression system (II)
The yield of synthesized GDP-D-rhamnose after the purification steps was determined
with HPLC. As calculated from GDP-D-mannose added to the cell lysates, 3-4% of
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the substrate was converted into GDP-D-rhamnose with the lysate of the S. cerevisiae
YPH501(pRHA2) strain. The yield of GDP-D-rhamnose was 9% in a sample in which
the lysates of yeast strains expressing either GMD or RMD were mixed together. In
the S. cerevisiae expression system, the concentration of endogenous GDP-D-mannose
has been shown to be the limiting factor for the synthesis of GDP-L-fucose by
recombinant bacterial enzymes (Mattila et al., 2000). Therefore, in order to generate
GDP-D-rhamnose in abundance, exogenous GDP-D-mannose was added to the reaction
mixture of the lysates of yeast strains expressing GMD and RMD. However, most of
the exogenously added GDP-D-mannose was observed to convert into something other
than GDP-D-rhamnose. It is likely that there are enzymes other than GMD in the
crude yeast lysate, such as mannosyltransferases (Kojima et al., 1999; Todorow et al.,
2000), which also compete for GDP-D-mannose. Furthermore, GDP-D-rhamnose might
inhibit the activity of GMD via feedback inhibition similar to GDP-L-fucose (Bisso et
al., 1999; Somoza et al., 2000; Sturla et al., 1997). A recent study on recombinant A.
thaliana GMD (named as MUR1) has demonstrated that GDP-D-rhamnose binds to
A. thaliana GMD in vitro, although A. thaliana is not known to synthesize GDP-D-
rhamnose (Mulichak et al., 2002). Thus, one could speculate that the yeast lysate co-
expressing GMD and RMD yielded a lower amount of GDP-D-rhamnose than the
mixture of lysates of yeast strains expressing either GMD or RMD due to the feedback
inhibition of GMD by GDP-D-rhamnose. Especially, since a similar phenomenon has
also been seen when compared the GDP-L-fucose yields of corresponding lysates of
yeast strains expressing H. pylori GMD and GMER (data not shown). However, this
comparison is not unequivocal, because protein concentrations of the recombinant
proteins were not determined. Purification of the GMD and RMD enzymes and
optimization of reaction conditions might lead to more efficient conversion of GDP-
D-mannose into GDP-D-rhamnose.
7.2.4. Conservation of RMD homologs among bacteria (II)
The amino acid sequence of RMD was used as a probe to find more putative RMD
sequences from the nucleotide or protein databases based on the sequence similarity.
Relatively high sequence similarities were found from the characterized A.
thermoaerophilus RMD as well as from three other bacterial ORFs of M. tuberculosis,
Thiobacillus ferrooxidans and Xylella fastidiosa. Of the three latter bacteria, T.
ferrooxidans is the only one known to express D-rhamnose as a constituent of its LPS
(Vinogradov et al., 1994). Significant sequence similarities were also found with GMD,
RmlB and GalE protein families. Therefore, selected gene sequences from the four
enzyme families were aligned to evaluate the distance inter se. The mutation rate was
used as a measure of distance between the sequences and standard phylogenetic tools
were used to visualize the result. The analysis showed that while the different genes
clustered according to their proposed function (Figure 6/II), their relatedness within
the group was not much higher than between the groups. This was further analyzed by
aligning the amino acid sequences from the RMD group: the sequences of P. aeruginosa
and A. thermoaerophilus with proven RMD activities, and the ORFs of T. ferrooxidans,
M. tuberculosis and X. fastidiosa (Figure 7/II). The sequences did not have any major
stretches of similarity, but rather short patterns, most of which are also found in the
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other three enzyme families (data not shown). Hence, prediction of enzymatic function
of the putative enzymes of these protein families on the basis of sequence comparison
may not be unequivocal, unless the sequence contains a typical motif, such as amino
acid sequence GILFNHES commonly found in GMDs (I; Kneidinger et al., 2001;
Somoza et al., 2000). Furthermore, before a reasonable comparison of evolutionary
relationships can be made more structural or enzyme activity data for these protein
families are required.
7.3. Methodological development for the analysis of nucleotide sugars (III)
7.3.1. Separation of nucleotide sugars by ion-pair reversed-phase HPLC (III)
An ion-pair reversed-phase chromatography with the volatile triethylammoniumacetate
(TEAA) buffer, which is a well-established technique used for separation of nucleotides
(Eriksson et al., 1986), was developed for the analysis of nucleotide sugars. The
potential of reversed-phase HPLC with TEAA buffer as an ion-pairing reagent was
evaluated with ten pure nucleotide sugars, e.g. GDP-D-mannose, GDP-D-rhamnose
and GDP-L-fucose (Figure 2/III). Negatively charged nucleotide sugars bound the
ion-pairing reagent and were retained on the HPLC column. They were eluted with a
gradient of increasing acetonitrile concentration. Of the ten nucleotide sugars tested,
eight were easily resolved, but UDP-N-acetyl-D-galactosamine and UDP-N-acetyl-D-
glucosamine had the same retention time. In separation of deoxyhexose nucleotides,
the method worked very well. Both GDP- and dTDP-deoxyhexoses were resolved
from the nucleotide hexoses that are their starting materials in the biosynthetic reactions.
7.3.2. Ion-pair solid-phase extraction of nucleotide sugars from cell lysates (III)
If nucleotide sugars from cell lysates are to be analyzed by reversed-phase HPLC,
they first need to be purified. Solid-phase extraction (SPE) columns containing
graphitized carbon were used for this step. Activated carbon in the form of charcoal
has been used as a preparative purification method for nucleotide sugars for decades
(Okazaki et al., 1962). SPE columns containing graphitized carbon have been used
for purification of oligosaccharides from salts, detergents, and proteins (Packer et al.,
1998). In this study, nucleotide sugars were found to adsorb tightly to carbon SPE
columns. They could be recovered quantitatively by adding the ion-pairing reagent
TEAA to the organic elution solvent.
The recovery of nucleotide sugars in purification with carbon SPE columns was tested
with pure nucleotide sugars. Nucleotide sugars were quantitatively adsorbed to carbon
SPE columns. Salts and unwanted, weakly bound materials were washed off from
columns with water and then with 25% acetonitrile and finally with 50 mM TEAA
buffer. As mentioned above, both the ion-pair reagent TEAA and the organic solvent
25% acetonitrile were required for the elution of nucleotide sugars. TEAA was removed
from the eluates by evaporation under vacuum prior to HPLC analysis. The recovery
of pure nucleotide sugars was almost complete, being in the range of 93-100% (Table
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1/III). The capacity of carbon columns was also tested with internal standard by adding
known concentrations of GDP-L-fucose to S. cerevisiae YPH501 lysate. The recovery
of GDP-L-fucose from the yeast lysate was almost 100% (Table 2/III), as with pure
nucleotide sugars. Defined by protein concentration, about 1 mg of yeast cell lysate
could be loaded into one 250 mg column without remarkable loss in recovery.
7.3.3. HPLC analysis of nucleotide sugars purified from lysates (I, II, III)
The newly developed reversed-phase HPLC in conjunction with the carbon SPE method
were used to analyze the nucleotide sugars from the lysates of recombinant S. cerevisiae
strains expressing bacterial enzymes synthesizing GDP-deoxyhexoses (I, II).
Synthesized nucleotide sugars were identified by comparison of retention times to
those of nucleotide sugar standards. Furthermore, some nucleotide sugar peaks obtained
from yeast extracts were also collected and analyzed with MALDI-TOF MS (Table 3/
III). In addition to endogenous UDP-N-acetylhexosamine of yeast, GDP-deoxyhexoses
synthesized by heterologously expressed bacterial enzymes and some uncharacterized
peaks were detected (Figure 3/III).
For most nucleotide sugars, the single-step purification of yeast lysates with carbon
SPE columns prior to HPLC analysis was found to be enough. However, impurity
peaks were seen to fuse with some nucleotide sugar peaks in the HPLC chromatograms
(Figure 3/III). Most of these unknown peaks were removed with alkaline phosphatase
treatment (Figure 4/III), which degrades nucleotides, but leaves nucleotide sugars intact.
This suggests that the uncharacterized peaks seen after graphite SPE purification were
mostly nucleotides. After the alkaline phosphatase treatment, samples were purified
with DEAE anion exchange columns using volatile NH4HCO3.
Reversed-phase HPLC and carbon SPE method combined with alkaline phosphatase
treatment and DEAE anion exchange purification were also used to analyze the enzyme
activities of P. aeruginosa synthesizing GDP-deoxyhexoses. No significant GDP-sugar
peaks were seen in the HPLC chromatogram of native P. aeruginosa (Figure 5/III,
panel A). However, the addition of GDP-D-mannose to the P. aeruginosa lysate boosted
the synthesis of GDP-D-rhamnose, which was detected in the HPLC chromatogram
(Figure 5/III, panel B).
Methods for the analysis of nucleotide sugar profiles of different cells will be a useful
tool in studying the regulation and abnormalities in glycosylation or in searching for
new enzymes producing nucleotide sugars. The developed SPE and HPLC methods
in sample processing and nucleotide sugar separation enable good separation of
structurally similar sugar nucleotides, as seen in the analysis of lysates of recombinant
S. cerevisiae strains and P. aeruginosa. These methods are suitable for both analytical
and preparative separation of nucleotide sugars, and they allow automation and
upscaling of sample volumes. Furthermore, SPE purification can be easier and more
rapidly performed in comparison to other sample preparation methods of nucleotide
sugars,  such as deproteinization with boiling (Albermann et al., 2000), perchlorate
(Martin et al., 1989), and organic solvents (Liljebjelke et al., 1995; Palmieri et al.,
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1991; Rush and Waechter, 1995; Tomiya et al., 2001). Ion-pair SPE is a less frequently
applied technique (Carson, 2000), but it offers many advantages over more conventional
SPE. The use of volatile TEAA buffer eliminates the need for further desalting prior
to HPLC, MS or NMR, which can be performed simply after evaporation of TEAA
under vacuum. This is advantageous as there are a limited amount of nucleotide sugar
standards commercially available, and MS or NMR may be needed to determine the
precise structure of the nucleotide sugar of interest. Interestingly, it seems that the
ion-pairing reagent TEAA works in opposite ways in carbon SPE and in reversed-
phase HPLC by either decreasing or increasing retention, respectively. Most probably
the developed SPE and HPLC could also be used in analysis and comparison of
nucleotide profiles of different cell types.
7.4. A. actinobacillus GDP-6-deoxy-D-talose synthetase (GTS) (IV)
7.4.1. Sequence comparison of GMER, RMD and GTS (I, II, IV)
From the gene cluster associated with the serotype a-SPA of A. actinomycetemcomitans
(Suzuki et al., 2000), a GDP-6-deoxy-D-talose synthetase (gts) gene was identified
on the basis of its amino acid sequence similarity with closely related bacterial
reductases responsible for the synthesis of other GDP-deoxyhexoses. The
corresponding gene product contained an N-terminal coenzyme-binding pattern
ThrGlyXXGlyXXGly, and an active-site pattern Ser-TyrXXXLys (Figure 2/IV), which
are the most typical motifs of the SDR protein family (Jörnvall et al., 1995). The
other conserved features of the SDR protein family, such as an NNAG motif or Asn111,
were not found (Filling et al., 2002; Oppermann et al., 2001). Additionally, these
former motifs of SDR protein family were present, while latter motifs were absent
from the sequences of other bacterial enzymes using GDP-4-keto-6-deoxy-D-mannose
as a substrate. Compared to those enzymes (Figure 2/IV), the putative GTS protein
shared 32% identity with E. coli GMER (Tonetti et al., 1998) and 28% identity with
H. pylori GMER (I). It also exhibited 30% identity with A. thermoaerophilus
(Kneidinger et al., 2001) and P. aeruginosa RMDs (II).
The amino acid sequence of GTS was more closely compared to that of E. coli GMER.
The crystallographic studies have indicated that a catalytic mechanism of GMER is
based on the concerted action of the evolutionarily conserved residues Ser107, Tyr136
and Lys140 (Rizzi et al., 1998; Rosano et al., 2000). These amino acid residues were
also present in the GTS sequence (Ser103, Tyr128 and Lys132). The GMER model
also indicated that the GDP-4-keto-6-deoxy-D-mannose substrate might be located in
the pocket facing Ser107, Ser108 and Cys109 residues (Rizzi et al., 1998; Rosano et
al., 2000). Neither Ser108 nor Cys109 were found in the GTS sequence. Moreover,
the E. coli GMER residues His179, which is suggested to play a role in the epimerisation
reaction (Rosano et al., 2000), and Arg187, which is considered to be part of the
substrate-binding cleft (Rizzi et al., 1998; Rosano et al., 2000), were absent from the
GTS sequence. In addition, the His179 residue was not found from the RMDs of A.
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thermoaerophilus and P. aeruginosa, whereas it was found from H. pylori GMER
(Figure 2/IV). The His179 residue of GMER enzyme was equivalent to the Phe residue
in RMD enzymes and GTS (Figure 2/IV), which are acting only as reductases. The
sequence alignment of GMERs, RMDs and GTS also showed that the GMER Arg187
equivalent residue was Gln178 in RMDs and Ala173 in GTS (Figure 2/IV). Amino
acid residue variations between the GDP-4-keto-6-deoxy-D-mannose exploiting
enzymes may be related to the different stereospecificity of the reduction reaction or
the order of reaction cascade (in the case of GDP-L-fucose synthesis epimerisation
occurs prior reduction). GMD is required to synthesize a GDP-4-keto-6-deoxy-D-
mannose substrate for GTS. Therefore, a putative gmd gene was also identified from
the serotype a-SPA gene cluster of A. actinomycetemcomitans. The corresponding
gene product shared 20% identity with characterized GMD proteins and it contains
the amino acid sequence GILFNHES which is commonly found in GMD (I; Kneidinger
et al., 2001; Somoza et al., 2000). The characterization of A. actinomycetemcomitans
GMD was not performed in this study.
7.4.2. Functional expression of GTS (IV)
The 885 bp gts gene was amplified from the chromosomal DNA of A.
actinomycetemcomitans serotype a and subcloned under the anhydrotetracycline
inducible tet promoter of the pASK-IBA5 expression vector in-frame with the N-
terminal Strep-tag II. In this study, IBA’s E. coli expression system was used for
overexpression of GTS (Table 1), because it enables the single-step affinity
chromatography purification of expressed Strep tagged fusion proteins and because
GTS was not expressed in the S. cerevisiae expression system. H. pylori gmd was also
subcloned into the same expression vector in-frame with N-terminal Strep-tag II,
because the characterized H. pylori GMD was needed to generate GDP-4-keto-6-
deoxy-D-mannose substrate for GTS. The resulting plasmids were used for
overexpression of the fusion proteins in E. coli BL21(DE3). The heterologous
expression of purified GMD and GTS was studied by SDS-PAGE. The molecular
masses determined by SDS-PAGE for the purified, denaturated GMD and GTS
corresponded to the calculated molecular masses of ca. 44 and 34 kDa, respectively
(Figure 3/IV, lanes 3 and 4). No corresponding bands were detected from the vector
control (Figure 3/IV, lanes 2). As judged from the negative control experiments with
the vector control, the few contaminating proteins purified along with GMD and GTS
were not responsible for the observed enzyme activity (Figure 4/IV).
7.4.3. Enzymatic activity of recombinant GTS (IV)
Incubation of recombinant E. coli lysates expressing GMD and GTS with exogenously
added GDP-D-mannose resulted in a new peak in the HPLC profile (data not shown).
This new compound was pooled from several HPLC runs and subjected to further
analysis with MALDI-TOF MS and NMR. MALDI-TOF MS showed that the new
molecule gave a single peak at m/z 588.08, which is identical to the mass of GDP-
deoxyhexoses (calculated m/z for [M-H]– is 588.08).
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The structure of the novel nucleotide sugar purified by HPLC was established to be
GDP-6-deoxy-talose by 1H NMR spectroscopy. Assignments of the proton signals
(Figure 5/IV) were obtained from a DQFCOSY spectrum (Figure 6/IV, panel B) and
proton-proton coupling constants 3JH,H+1 (Table I/IV) were determined by a first order
analysis. The 1H chemical shifts of the hexosyl unit (Table I/IV) were clearly different
from those obtained for GDP-D-rhamnose (Table 2/II) or GDP-L-fucose (Adelhorst
and Whitesides, 1993). The small coupling constants between the ring protons of the
hexosyl unit were characteristic of a mannoconfiguration at position C2 and of a
galactoconfiguration at position C4 and thus confirms the hexosyl unit as 6-deoxy-
talose. In addition, a cross-peak was observed in the DQFCOSY spectrum between
H2 and H4 of the deoxytalosyl unit (Figure 6/IV, panel B). This four-bond coupling
arises from the planar W orientation of the bonds (Figure 6/IV, panel A).  Such long-
range couplings are rarely observed in carbohydrates, because a similar pair of
equatorial protons does not exist in the most common monosaccharide units. Therefore,
the observed coupling further confirms the mutual orientation of H2 and H4 as
equatorial-equatorial.
After having GDP-6-deoxy-D-talose standard characterized by MALDI-TOF MS and
NMR (Figure 4/IV, lane E), nucleotide sugars formed in the reactions of purified Strep
tagged GMD and GTS with exogenously added GDP-D-mannose and NADP+ and/or
NADPH were analyzed with reversed-phase HPLC (Figure 4/IV). In the HPLC
analysis, the reaction mixture containing GMD gave a peak representing the GDP-4-
keto-6-deoxy-D-mannose intermediate (Figure 4/IV, lane C). The presence of GDP-4-
keto-6-deoxy-D-mannose in the reaction mixture was studied by a chemical reduction
with NaBH4. After the chemical reduction, two new peaks, GDP-D-rhamnose and
GDP-6-deoxy-D-talose were detected with HPLC (data not shown). The GDP-4-keto-
6-deoxy-D-mannose peak was not detected from the reaction mixture containing GMD
and GTS, instead a novel peak with the same retention time as the GDP-6-deoxy-D-
talose standard was observed (Figure 4/IV, lane D). GDP-4-keto-6-deoxy-D-mannose
or GDP-6-deoxy-D-talose peaks were not detected from the vector control (Figure 4/
IV, lane B). The data from the HPLC chromatograms was very solid, because carbon
SPE purification of reaction mixtures containing purified enzymes together with
cofactors and substrates yielded only GDP-sugars that indicated the biochemical
activities of GMD and GTS (Figure 4/IV). The addition of NADPH as a cofactor was
required for the GTS activity. Because no reverse reaction or other reaction products
were detected in HPLC analysis, the conversion of GDP-4-keto-6-deoxy-D-mannose
to GDP-6-deoxy-D-talose by GTS proceeded quantitatively and specifically. The
identification and biochemical activity of A. actinomycetemcomitans GTS was also
confirmed by an independent study by Suzuki and colleagues (2002).
A. thermoaerophilus GMD has been demonstrated to be a bifunctional enzyme acting
as a GDP-D-mannose 4,6-dehydratase and GDP-4-keto-6-deoxy-D-mannose reductase
(Kneidinger et al., 2001). In this study, the bifunctionality of purified H. pylori GMD
was not observed suggesting that the specificity of GMD enzymes varies among
bacterial species. Furthermore, the expressed GMD and GDP-4-keto-6-deoxy-D-
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mannose utilizing enzymes were stable and active as fusion proteins with N-terminal
c-myc-, FLAG- or Strep-tags. There are reports that the recombinant E. coli GMD, V.
cholerae GMD and E. coli GMER have not been active or stable when expressed
natively or as an N-terminal fusion with His-tag (Albermann et al., 2000; Albermann
and Piepersberg, 2001; Sturla et al., 1997).
7.4.4. Synthesis of GDP-6-deoxy-D-talose by purified GTS (IV)
The yield of synthesized GDP-6-deoxy-D-talose by purified GMD and GTS after the
purification steps was determined with HPLC. As calculated from the GMD reaction
product, GDP-4-keto-6-deoxy-D-mannose, 79% of the substrate was converted into
GDP-6-deoxy-D-talose. The remaining (21%) GDP-4-keto-6-deoxy-D-mannose was
not detected in HPLC analysis probably due to the labile nature of GDP-4-keto-6-
deoxy-D-mannose (Bonin and Reiter, 2000; Kneidinger et al., 2001). As calculated
from GDP-D-mannose added to the reaction mixture containing GMD, 14% of GDP-
D-mannose was converted into GDP-6-deoxy-D-talose by GTS. Optimization of
reaction conditions might lead to a more efficient conversion of GDP-D-mannose into
GDP-6-deoxy-D-talose. In general, purification of enzymes enables kinetic studies of
enzyme reaction, but in this study the kinetic parameters of GTS were not analyzed
due to the instability of GDP-4-keto-6-deoxy-D-mannose.
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This study involved the molecular identification and enzymatic characterization of
nucleotide sugar synthesizing enzymes, that produce GDP-L-fucose, GDP-D-rhamnose
and GDP-6-deoxy-D-talose. Enzymes were identified from the pathogenic bacteria H.
pylori, P. aeruginosa and A. actinomycetemcomitans serotype a, in which deoxyhexoses
L-fucose, D-rhamnose, 6-deoxy-D-talose are constituents of LPS, respectively.  The
specific functions of LPS molecules containing these deoxyhexoses in the course of
colonization and infection are unknown. However, the relevance of LPS in pathogenesis
of these bacteria is under extensive studies.
The biosyntheses of GDP-L-fucose, GDP-D-rhamnose and GDP-6-deoxy-D-talose have
received increased interest after L-fucose, D-rhamnose, and 6-deoxy-D-talose were
shown to be substantial cell wall components of several human pathogens. Some of
these pathogens, which can cause community-acquired diseases or nosocomial
infections, are multiple drug-resistant. Although a large number of antibacterial drugs
are available, most of them target the same cellular process or even the same target
enzyme leading to the potential for cross-resistance. Multiple drug-resistance and cross-
resistance of pathogens creates a high demand for therapeutics acting with new
strategies. New drugs with novel functions may be discovered from the biosynthetic
pathways of glycoconjugates or glycosyltransferases. If the roles of fucosylation/
rhamnosylation/talosylation are determined to be essential for the viability of the
microorganism or the host – pathogen interaction, the enzymes involved in the
biosynthesis of these glycoforms could be suitable targets for antibacterial agents.
Humans lack rhamnosylation and talosylation and would thus most likely not suffer
from the inhibition of metabolism related to these glycoforms.
L-fucose is the only representative of these three deoxyhexoses also found in eukaryotes.
Nevertheless, the biosynthetic de novo pathway of GDP-L-fucose could also be
considered as a potential therapeutic target, because humans, as well as other eukaryotes,
have an alternative pathway for GDP-L-fucose biosynthesis. This pathway is a result
of the ‘salvage’ metabolism, which uses fucose derived from lysosomal degradation
or nutrition (reviewed in Bulter and Elling, 1999). Smith and colleagues (2002) have
shown that the de novo pathway knock-out mice grew normally when fed with fucose-
supplemented food. If in humans, dietary or salvaged fucose also makes a substantial
contribution to the fucosylation, defect caused by the short-term inhibition of the
enzymes involved in the de novo pathway of GDP-L-fucose, might not cause suffering
in humans. The de novo biosynthesis of GDP-L-fucose can also be a target for
therapeutical treatment of pathological conditions of abnormal selectin-mediated cell-
to-cell interaction, such as leukocyte trafficking into sites of inflammation (Kirveskari
et al., 2001; reviewed in Lowe, 2001) or in bacterial adherence to host fucosylated
glycans (Herron et al., 2000; reviewed in Hooper and Gordon, 2001). Inhibition of the
de novo biosynthesis of GDP-L-fucose may reduce the effective synthesis of fucosylated
8. CONCLUSIONS AND FUTURE PROSPECTS
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ligands and thus interfere cell-to-cell interaction or cell adhesion in these pathological
conditions.
Understanding the mechanism of biosynthesis of these nucleotide sugars should aid
in the rational design of drugs with potential in antibacterial or anti-inflammatory
chemotherapy. Hence, the detailed studies of the discrete catalytic mechanisms of the
reactions and the specific regulation sites of GMD, GMER, RMD, and GTS are needed.
Analysis of these closely related enzymes would also contribute to the understanding
of catalytic mechanism of other dehydratases, epimerases or reductases belonging to
the SDR protein family that could also be considered as targets for antimicrobial agents,
such as the enzymes involved in the biosynthesis of dTDP-L-rhamnose. Disruption of
the dTDP-L-rhamnose pathway has the attenuated virulence or influenced the viability
of pathogenic bacteria, e.g. V. cholerae, Enterococcus feacalis and Streptococcus mutans
(Chiang and Mekalanos, 1999; Xu et al., 2000; Yamashita et al., 1999). These
observations elucidate the importance in bacterial pathogenicity of enzymes involved
in the biosynthesis of LPS or capsular sugars.
The prevalence of the GDP-L-fucose, GDP-D-rhamnose, and GDP-6-deoxy-D-talose
pathways is not high, but narrow-spectrum drugs may be of interest in certain disease
states like chronic infections that require long-term treatment. Furthermore, narrow-
spectrum agents would also minimize the spread of drug resistance to other pathogens.
It is worth mentioning that in addition to the GDP-L-fucose, GDP-D-rhamnose, and
GDP-6-deoxy-D-talose pathways, the inhibition of GMD activity would also influence
the biosynthesis of GDP-D-perosamine and GDP-colitose. D-perosamine is a constituent
of glycoconjugates in several Gram-positive and Gram-negative bacteria, e.g. E. coli
O:157, V. cholerae O:1 and Y. enterocolitica O:9 (Bilge et al., 1996; Villeneuve et al.,
2000; reviewed in Skurnik and Zhang, 1996). Colitose is a constituent of LPS in
Gram-negative bacteria, e.g. E. coli O:111, S. enterica O:35 and Y. pseudotuberculosis
O:6 and O:7 (Wang and Reeves, 2000; reviewed in Skurnik and Zhang, 1996). Humans
lack metabolism for both of these nucleotide sugars.
Naturally, before the biosynthetic pathways of GDP-L-fucose, GDP-D-rhamnose, and
GDP-6-deoxy-D-talose could be considered as therapeutic targets, the possible roles
of fucosylation/rhamnosylation/talosylation in the viability or virulence of pathogenic
bacteria should be determined. Pathogenesis models will permit the identification of
the virulence factors as well as the elucidation of the efficacy of potential
chemotherapeutic agent. For instance, there are several pathogenesis models for H.
pylori (reviewed in Nedrud, 1999), P. aeruginosa (reviewed in Andes and Craig, 1998;
Stotland et al., 2000) and A. actinomycetemcomitans (Kawai et al., 1998; Sosroseno
and Herminajeng, 2002). The ability of P. aeruginosa to infect a variety of plant,
invertebrate and vertebrate hosts has also enabled the development of rapid pathogenesis
models using for example A. thaliana or Caenorhabditis elegans as a host (Rahme et
al., 1995; Tan et al., 1999). Furthermore, it has been observed that several factors that
affect the P. aeruginosa – plant/nematode infections also operate in the P. aeruginosa
– mammal infections (Mahajan-Miklos et al., 1999; Rahme et al., 2000). Pathogenesis
models and the developments in  microarray technology and the whole-genome analysis
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of host organisms will also allow the role of the host factors to be evaluated. This is
especially important when studying the influence of inhibition of  metabolic pathways
which exist both in pathogen and host organisms, as is the case of the GDP-L-fucose
pathway.
Research groups studying the relevance of glycoforms of various bacteria would benefit
from the availability of building blocks required for the synthesis of glycosylated
molecules. Before these molecules can be synthesized in vitro, the activated nucleotide
sugars and the corresponding glycosyltransferases catalyzing the formation of specific
glycosidic linkages are needed. Fucosyltransferases with different acceptor and linkage
specificities have been characterized from a limited number of bacteria (reviewed in
Oriol et al., 1999; Wang et al., 2000), however the enzymatic characterization of
identified D-rhamnosyltrasferases (Rocchetta et al., 1998) or identification and
characterization of deoxytalosyltransferases remains to be done. This study provides
three different nucleotide sugars, which can be utilized in characterization of
glycosyltransferases or in oligosaccharide synthesis.
This study also provides a novel method for the analysis of the cellular nucleotide
sugar pool. This newly developed reversed-phase HPLC can also be used in preparative
oligosaccharide synthesis or to study regulation or inhibition of enzymes involved in
the synthesis of nucleotide sugars. In general, there are not many methods available
for carbohydrate chemistry in comparison to available methods for genomics or
proteomics. Hence, any methodological development for studies of carbohydrate
chemistry or “glycomics” is valuable.
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